acetazolamide has been researched along with Altitude Hypoxia in 277 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Altitude Hypoxia: Low ambient oxygen tension associated with ALTITUDE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acetazolamide has complex effects on ventilation, PVR, and CBF that converge to optimize brain oxygenation and may be a valuable means to prevent/treat high-altitude pulmonary edema." | 9.12 | Effects of acetazolamide on ventilatory, cerebrovascular, and pulmonary vascular responses to hypoxia. ( Balanos, GM; Brown, AD; Duff, HJ; Foster, GE; Leigh, R; Poulin, MJ; Steinback, CD; Teppema, LJ, 2007) |
| " The acetazolamide-dexamethasone prophylaxis appears beneficial in promoting pulmonary acclimatisation during hypobaric hypoxia." | 9.10 | Hypoxia and pulmonary acclimatisation at 4578 m altitude: the role of acetazolamide and dexamethasone. ( Aslam, M; Hussain, MM, 2003) |
| "The aim of the study was to assess effects of acetazolamide in prevention of acute mountain sickness (AMS) and on overnight oxygenation, in patients with asthma treated at the altitude of 3,200 m." | 9.07 | Effects of acetazolamide on overnight oxygenation and acute mountain sickness in patients with asthma. ( Brimkulov, N; Cieslicki, J; Kudaiberdiev, Z; Mirrakhlmov, M; Moldotashev, I; Shmidt, G; Tobiasz, M; Zielinski, J, 1993) |
| "Low doses of the carbonic anhydrase inhibitor acetazolamide provides accelerated acclimatization to high-altitude hypoxia and prevention of cerebral and other symptoms of acute mountain sickness." | 7.81 | Acetazolamide during acute hypoxia improves tissue oxygenation in the human brain. ( Buxton, RB; Dubowitz, DJ; Smith, ZM; Swenson, ER; Wang, K, 2015) |
| "We tested the effect of acetazolamide on blood mechanical properties and pulmonary vascular resistance (PVR) during chronic hypoxia." | 7.78 | Acetazolamide and chronic hypoxia: effects on haemorheology and pulmonary haemodynamics. ( Brunet, J; Connes, P; Cymbalista, F; Favret, F; Levy, BI; Maignan, M; Marchant, D; Pichon, A; Quidu, P; Richalet, JP; Safeukui, I; Vilar, J, 2012) |
| "Acute mountain sickness is a common occurrence for travel to high altitudes." | 6.90 | Altitude Sickness Prevention with Ibuprofen Relative to Acetazolamide. ( Burns, P; Hackett, P; Jurkiewicz, C; Lipman, GS; Phillips, C; Sanders, L; Soto, M; Warner, K, 2019) |
| "Ibuprofen was similar to acetazolamide in preventing symptoms of AMS, an interesting finding that implies a potentially new approach to prevention of cerebral forms of acute altitude illness." | 6.75 | Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation at Altitude Trial (HEAT). ( Allison, E; Basnyat, B; Fisher, RS; Gertsch, JH; Hanzelka, K; Hazan, A; Holck, PS; Lipman, GS; Merritt, A; Meyers, Z; Mulcahy, A; Odegaard, J; Pook, B; Slomovic, B; Thompson, M; Wahlberg, H; Weiss, EA; Wilshaw, V; Zafren, K, 2010) |
| "Acetazolamide treatment ameliorates the symptoms of AMS; however, the mechanism by which this occurs is unclear." | 6.67 | The effects of acetazolamide on the ventilatory response to high altitude hypoxia. ( Burki, NK; Hameed, MA; Khan, SA, 1992) |
| "A handful of case reports also describe choroidal effusions secondary to its use as part of ophthalmic treatment (eg, postoperatively)." | 5.72 | Bilateral choroidal effusions after taking acetazolamide for altitude sickness. ( Anderson, O; Rothwell, A, 2022) |
| " This study aimed to determine whether acetazolamide is effective at dosing relevant to human use at high altitude and to investigate whether its efficacy against hypoxic pulmonary vasoconstriction is dependent on carbonic anhydrase inhibition by testing other potent heterocyclic sulfonamide carbonic anhydrase inhibitors." | 5.34 | Pulmonary vasodilation by acetazolamide during hypoxia is unrelated to carbonic anhydrase inhibition. ( Boemke, W; Francis, RC; Höhne, C; Pickerodt, PA; Swenson, ER, 2007) |
| "1) To investigate the impact of acetazolamide, a drug commonly prescribed for altitude sickness, on cortical oscillations in patients with obstructive sleep apnea syndrome (OSAS)." | 5.19 | Impact of acetazolamide and CPAP on cortical activity in obstructive sleep apnea patients. ( Achermann, P; Bloch, KE; Kohler, M; Latshang, TD; Nussbaumer-Ochsner, Y; Stadelmann, K; Tarokh, L; Ulrich, S, 2014) |
| "We assessed the haemodynamic changes induced by exposure to high altitude hypoxia and the effects on them of acetazolamide, a drug prescribed to prevent and treat mountain sickness." | 5.17 | Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposure. ( Bilo, G; Faini, A; Giuliano, A; Gregorini, F; Lisi, E; Lombardi, C; Mancia, G; Parati, G; Ramos Becerra, CG; Revera, M; Salerno, S; Salvi, P, 2013) |
| "In this randomized, double-blind placebo controlled trial our objectives were to determine if acetazolamide is capable of preventing high altitude pulmonary edema (HAPE) in trekkers traveling between 4250 m (Pheriche)\\4350 m (Dingboche) and 5000 m (Lobuje) in Nepal; to determine if acetazolamide decreases pulmonary artery systolic pressures (PASP) at high altitude; and to determine if there is an association with PASP and signs and symptoms of HAPE." | 5.13 | Acetazolamide fails to decrease pulmonary artery pressure at high altitude in partially acclimatized humans. ( Alekh, K; Basnyat, B; Basnyat, R; Davis, C; Farrar, JJ; Ghimire, LV; Griffiths, A; Hargrove, J; Holck, PS; Johnson, DW; Kaul, K; Pandey, K; Paudyal, A; Robinson, C; Shandley, T; Shankar, R; Southard, A; Srivastav, S; Stasiuk, D; Swenson, ER; Weiss, EA; Williams, S; Zafren, K, 2008) |
| "Although the effects of acetazolamide (ACZ) on ventilation during acute mountain sickness are well known, there are no studies assessing its effect on ventilatory response in chronic hypoxia." | 5.13 | Effect of acetazolamide on ventilatory response in subjects with chronic mountain sickness. ( Bouchet, P; Huicho, L; León-Velarde, F; Richalet, JP; Rivera-Ch, M, 2008) |
| "Acetazolamide has complex effects on ventilation, PVR, and CBF that converge to optimize brain oxygenation and may be a valuable means to prevent/treat high-altitude pulmonary edema." | 5.12 | Effects of acetazolamide on ventilatory, cerebrovascular, and pulmonary vascular responses to hypoxia. ( Balanos, GM; Brown, AD; Duff, HJ; Foster, GE; Leigh, R; Poulin, MJ; Steinback, CD; Teppema, LJ, 2007) |
| " The acetazolamide-dexamethasone prophylaxis appears beneficial in promoting pulmonary acclimatisation during hypobaric hypoxia." | 5.10 | Hypoxia and pulmonary acclimatisation at 4578 m altitude: the role of acetazolamide and dexamethasone. ( Aslam, M; Hussain, MM, 2003) |
| "The aim of the study was to assess effects of acetazolamide in prevention of acute mountain sickness (AMS) and on overnight oxygenation, in patients with asthma treated at the altitude of 3,200 m." | 5.07 | Effects of acetazolamide on overnight oxygenation and acute mountain sickness in patients with asthma. ( Brimkulov, N; Cieslicki, J; Kudaiberdiev, Z; Mirrakhlmov, M; Moldotashev, I; Shmidt, G; Tobiasz, M; Zielinski, J, 1993) |
| " Acetazolamide is a medication commonly used to prevent acute mountain sickness, but it has an uncommon side effect of transient myopia." | 3.83 | Myopic Changes in a Climber after Taking Acetazolamide and the Use of Corrective Lenses to Temporize Symptoms: A Case Report from Mount Kilimanjaro. ( Hill, AD, 2016) |
| " Upon presentation to an emergency clinic, diabetic ketoacidosis (DKA) was diagnosed and was managed with insulin, intravenous fluids with potassium, and acetazolamide orally." | 3.81 | Diabetic ketoacidosis and acute mountain sickness: case report and review of treatment options in type 1 diabetes mellitus. ( Miller, SC, 2015) |
| "Low doses of the carbonic anhydrase inhibitor acetazolamide provides accelerated acclimatization to high-altitude hypoxia and prevention of cerebral and other symptoms of acute mountain sickness." | 3.81 | Acetazolamide during acute hypoxia improves tissue oxygenation in the human brain. ( Buxton, RB; Dubowitz, DJ; Smith, ZM; Swenson, ER; Wang, K, 2015) |
| "We tested the effect of acetazolamide on blood mechanical properties and pulmonary vascular resistance (PVR) during chronic hypoxia." | 3.78 | Acetazolamide and chronic hypoxia: effects on haemorheology and pulmonary haemodynamics. ( Brunet, J; Connes, P; Cymbalista, F; Favret, F; Levy, BI; Maignan, M; Marchant, D; Pichon, A; Quidu, P; Richalet, JP; Safeukui, I; Vilar, J, 2012) |
| "We describe the case of a 38-year-old man who presented with bilateral retinal detachments following a trek in Tibet during which time he took acetazolamide for prophylaxis of acute mountain sickness (AMS)." | 3.74 | High altitude and retinal detachment. ( Cottrell, DG; Morris, DS; Severn, PS; Smith, J; Somner, JE; Stannard, KP, 2007) |
| "We have studied the effect of acetazolamide 500 mg bd for three days on ventilatory response to CO2 (HCVR) and hypoxia under both isocapnic and poikilocapnic conditions (isocapnic and poikilocapnic HVR) in five normal subjects." | 3.68 | The effect of acetazolamide on hypercapnic and eucapnic/poikilocapnic hypoxic ventilatory responses in normal subjects. ( Bashir, Y; Kann, M; Stradling, JR, 1990) |
| "Acetazolamide is the most common medication used for acute mountain sickness prevention, with speculation that a reduced dose may be as efficacious as standard dosing with fewer side effects." | 2.94 | A Randomized Controlled Trial of the Lowest Effective Dose of Acetazolamide for Acute Mountain Sickness Prevention. ( Burnier, A; Hawkins, J; Jurkiewicz, C; Lipman, GS; Lowry, C; Marvel, J; Navlyt, A; Phillips, C; Swenson, ER, 2020) |
| " Further research with more participants with greater rates of AMS would further elucidate this reduced dosage for preventing altitude illness." | 2.90 | Reduced Acetazolamide Dosing in Countering Altitude Illness: A Comparison of 62.5 vs 125 mg (the RADICAL Trial). ( Basnyat, B; Dow, J; Ghale, M; Gurung, TY; Hemphill, M; K Grissom, C; Knott, JR; McDevitt, MC; McIntosh, SE; Thapa, GB; Weber, DC, 2019) |
| "Acute mountain sickness is a common occurrence for travel to high altitudes." | 2.90 | Altitude Sickness Prevention with Ibuprofen Relative to Acetazolamide. ( Burns, P; Hackett, P; Jurkiewicz, C; Lipman, GS; Phillips, C; Sanders, L; Soto, M; Warner, K, 2019) |
| "Acetazolamide was available to any participant desiring prophylaxis." | 2.82 | Acute Mountain Sickness Symptom Severity at the South Pole: The Influence of Self-Selected Prophylaxis with Acetazolamide. ( Anderson, PJ; Harrison, MF; Johnson, BD; Johnson, JB; Miller, AD; Richert, M, 2016) |
| " The data show that a low prophylactic dosage of acetazolamide, but not gingko biloba, mitigates the early increase of PASP in a quick ascent profile." | 2.78 | Effect of acetazolamide and gingko biloba on the human pulmonary vascular response to an acute altitude ascent. ( Chen, J; Chen, Y; Hu, Y; Ke, T; Liu, M; Luo, W; Shen, X; Swenson, ER; Wang, J; Yang, Q; Zhang, W; Zhang, X; Zhao, F, 2013) |
| "Acetazolamide was more effective than spironolactone in preventing AMS (OR = 0." | 2.76 | Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (spironolactone and acetazolamide trial in the prevention of acute mountain sickness group). ( Alexander, HD; Basnyat, B; Farrar, J; Gertsch, J; Halverson, S; Holck, PS; Joshi, A; Karambay, J; Khanal, S; Morrissey, C; Powell, S; Pun, M; Shankar, R; Steif, M; Stone, A; Szawarski, P; Thompson, BH, 2011) |
| "Ibuprofen was similar to acetazolamide in preventing symptoms of AMS, an interesting finding that implies a potentially new approach to prevention of cerebral forms of acute altitude illness." | 2.75 | Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation at Altitude Trial (HEAT). ( Allison, E; Basnyat, B; Fisher, RS; Gertsch, JH; Hanzelka, K; Hazan, A; Holck, PS; Lipman, GS; Merritt, A; Meyers, Z; Mulcahy, A; Odegaard, J; Pook, B; Slomovic, B; Thompson, M; Wahlberg, H; Weiss, EA; Wilshaw, V; Zafren, K, 2010) |
| " We conclude that 125 mg bd of acetazolamide is not significantly different from 375 mg bd in the prevention of AMS; 125 mg bd should be considered the preferred dosage when indicated for persons ascending to altitudes above 2500 m." | 2.72 | Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial. ( Basnyat, B; Donham, BP; Fleischman, RJ; Gertsch, JH; Gowder, DW; Hawksworth, JS; Holck, PS; Jensen, BT; Johnson, EW; Kleiman, RJ; Loveridge, AH; Luks, AM; Lundeen, EB; Miegs, DP; Newman, SL; Noboa, JA; O'Beirne, KA; Philpot, KB; Schultz, MN; Swenson, ER; Valente, MC; Wiebers, MR, 2006) |
| "Acetazolamide was tolerable, but impractical for the routine prevention of AMS in Nepali porters." | 2.72 | Prevention of acute mountain sickness by acetazolamide in Nepali porters: a double-blind controlled trial. ( Bajracharya, R; Gurung, P; Hillenbrand, P; Lal, BK; Marahatta, R; Pahari, AK; Pradhan, S; Rai, D; Sharma, S; Soon, Y; Subedi, D, 2006) |
| "Medroxyprogesterone acts as a respiratory stimulant, but the clinical benefit regarding the development of AMS was unproven at high altitude." | 2.71 | Medroxyprogesterone at high altitude. The effects on blood gases, cerebral regional oxygenation, and acute mountain sickness. ( Beazley, MF; Bradwell, AR; Chesner, IM; Clayton, RN; Forster, PJ; Hillenbrand, P; Imray, CH; Wright, AD, 2004) |
| " A comparison of a difference in decline in average AMS score over time showed a statistically significant decline for the 250-mg dosing group versus placebo (p = 0." | 2.71 | A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m). ( Carlsten, C; Ruoss, S; Swenson, ER, 2004) |
| "Hypoxemia is the immediate consequence of hyobaric hypoxia, which is the crucial starting mechanism of acute mountain sickness (AMS)." | 2.70 | Acute mountain sickness score and hypoxemia. ( Aslam, M; Hussain, MM; Khan, Z, 2001) |
| " The Fel (fraction eliminated unchanged in urine) was calculated from the amount excreted in 36 h in urine and dose, assuming a bioavailability of 1 based on literature data." | 2.69 | Urinary excretion of acetazolamide in healthy volunteers after short- and long-term exposure to high altitude. ( Agrawal, MA; Arancibia, A; Lücker, PW; Paulos, C; Ritschel, WA; Wetzelsberger, KM, 1998) |
| "Acetazolamide 250 mg was administered orally to young, healthy male volunteers in groups of 12 each: those residing at sea level (group L), these same volunteers on the day after arrival at high altitude (4,360 m, group HA), and volunteers living at high altitude for 10 months or longer (group HC)." | 2.69 | Pharmacokinetics of acetazolamide in healthy volunteers after short- and long-term exposure to high altitude. ( Agrawal, MA; Arancibia, A; Lücker, PW; Paulos, C; Ritschel, WA; Wetzelsberger, KM, 1998) |
| "Acetazolamide treatment ameliorates the symptoms of AMS; however, the mechanism by which this occurs is unclear." | 2.67 | The effects of acetazolamide on the ventilatory response to high altitude hypoxia. ( Burki, NK; Hameed, MA; Khan, SA, 1992) |
| "Methazolamide can increase systemic metabolic acidosis and sequentially improve ventilation and oxygenation level." | 2.66 | Methazolamide in high-altitude illnesses. ( Jiang, Y; Lu, H; Zhang, H, 2020) |
| "Acute mountain sickness is a common condition occurring in healthy subjects that undergo rapid ascent without prior acclimatization, as low as 2500 meters above sea level." | 2.66 | Ibuprofen versus acetazolamide for prevention of acute mountain sickness. ( Irarrázaval, S; Schilling, M, 2020) |
| "Methazolamide (150 mg/d) was as effective as acetazolamide (500 mg/d) in preventing the symptoms of acute mountain sickness in 20 subjects ascending to 4985 m." | 2.65 | Methazolamide and acetazolamide in acute mountain sickness. ( Bradwell, AR; Fletcher, RF; Wright, AD, 1983) |
| "Acetazolamide was acceptable to 23 of the 24 subjects." | 2.65 | Acetazolamide in prevention of acute mountain sickness: a double-blind controlled cross-over study. ( Greene, MK; Kerr, AM; McIntosh, IB; Prescott, RJ, 1981) |
| "Acute mountain sickness is the most prevalent illness related to acute exposure to high altitude, secondary to the hypobaric hypoxia effects in our body." | 2.61 | Acetazolamide for the treatment of acute mountain sickness. ( Irarrázaval, S; Tapia, L, 2019) |
| " However, evidence indicates that reduced dosage schemes compared to the current recommendations are warranted." | 2.58 | Advances in the available non-biological pharmacotherapy prevention and treatment of acute mountain sickness and high altitude cerebral and pulmonary oedema. ( Balanos, GM; Imray, CHE; Joyce, KE; Lucas, SJE; Wright, AD, 2018) |
| "In animal experiments, cerebral edema caused by hypobaric hypoxia was associated with an increased expression of AQP-4 by astrocytes." | 2.58 | Possible Role of Glymphatic System of the Brain in the Pathogenesis of High-Altitude Cerebral Edema. ( Czaja, J; Latacz, P; Simka, M, 2018) |
| "Patients with obstructive sleep apnea at altitude." | 2.52 | Patients with Obstructive Sleep Apnea at Altitude. ( Bloch, KE; Latshang, TD; Ulrich, S, 2015) |
| "Acetazolamide was associated with a reduction in acute mountain sickness symptoms, with a number needed to treat ranging from 8 to 3 among 3 trials and at doses ranging from 250 to 750 mg daily." | 2.48 | Pharmacologic prophylaxis for acute mountain sickness: a systematic shortcut review. ( Emmett, TW; Malka, ST; Seupaul, RA; Welch, JL, 2012) |
| "The risk of paresthesia was increased with all doses." | 2.48 | Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis. ( Combescure, C; Dumont, L; Haller, G; Kayser, B; Lysakowski, C; Tramèr, MR, 2012) |
| " Other agents commonly used at sea-level such as eszopiclone and diphenhydramine have not been studied at high altitude but are likely safe to use given their mechanism of action and known side effects." | 2.44 | Which medications are safe and effective for improving sleep at high altitude? ( Luks, AM, 2008) |
| "High-altitude pulmonary edema is a non-cardiac edema that often precedes acute mountain sickness." | 2.42 | [Visiting high altitudes--healthy persons and patients with risk diseases]. ( Fischer, R, 2004) |
| "Acetazolamide 750 mg was also efficacious (2." | 2.41 | Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review. ( Dumont, L; Mardirosoff, C; Tramèr, MR, 2000) |
| "High altitude pulmonary edema presents in roughly twenty percent of the cases with mild symptoms of acute mountain sickness or even without any symptoms at all." | 2.41 | [Mountaineering and altitude sickness]. ( Maggiorini, M, 2001) |
| "Acetazolamide has been used in a dosage of 250 to 500 mg 12 to 24 h." | 2.38 | [Prevention and therapy of altitude sickness]. ( Maggiorini, M, 1993) |
| "Acute mountain sickness has long been recognized as a potentially life-threatening condition afflicting otherwise healthy individuals who ascend rapidly to high altitude, where the partial pressure of oxygen in the air is reduced." | 2.38 | Pharmacological control of altitude sickness. ( Coote, JH, 1991) |
| "High-altitude retinal hemorrhage may be related to similar vascular events in the retinal circulation." | 2.37 | Altitude-related illness. ( Foulke, GE, 1985) |
| "Acetazolamide prophylaxis was associated with decreased risk of AMS." | 1.72 | Risk factors for acute mountain sickness in travellers to Cusco, Peru: coca leaves, obesity and sex. ( Cabada, MM; Caravedo, MA; Morales, ML; Mozo, K; Smiley, H; Stuart, J; Tilley, DH, 2022) |
| "A handful of case reports also describe choroidal effusions secondary to its use as part of ophthalmic treatment (eg, postoperatively)." | 1.72 | Bilateral choroidal effusions after taking acetazolamide for altitude sickness. ( Anderson, O; Rothwell, A, 2022) |
| "Acetazolamide was administered in the drinking water (62 mg/kg/day) for four weeks, and zoledronate (100 μg/kg) was administered as a single subcutaneous injection at study start." | 1.72 | Effect of Acetazolamide and Zoledronate on Simulated High Altitude-Induced Bone Loss. ( Brent, MB; Brüel, A; Simonsen, U; Thomsen, JS, 2022) |
| "Acute diarrhea was the most common ailment reported among the participants (18%), followed closely by musculoskeletal problems (17%)." | 1.56 | Morbidity Among Athletes Presenting for Medical Care During 3 Iterations of an Ultratrail Race in the Himalayas. ( Basyal, B; Dawadi, S; Subedi, Y, 2020) |
| "The use of prophylactic acetazolamide in a dosage of 125 mg every 12 h is highly effective at diminishing the risk of HAI." | 1.56 | The use of acetazolamide for the prevention of high-altitude illness. ( Shlim, DR, 2020) |
| "Preventing high altitude cerebral edema in rats with repurposed anti-angiogenesis pharmacotherapy." | 1.43 | Preventing High Altitude Cerebral Edema in Rats with Repurposed Anti-Angiogenesis Pharmacotherapy. ( Irwin, DC; Loomis, Z; Maltzahn, J; Tarshis, S, 2016) |
| "Acetazolamide was used at least once by 90% of subjects and, of those who used acetazolamide, 92% began taking it on day 1 of the ascent." | 1.40 | A retrospective study of acute mountain sickness on Mt. Kilimanjaro using trekking company data. ( Eigenberger, P; Faino, A; Frank, A; Frank, E; Irwin, D; Lisk, C; Loomis, Z; Maltzahn, J; Schroeder, T; Strand, M, 2014) |
| "Acetazolamide prophylaxis was not protective, with a greater proportion of OC users (100%) developing AMS despite its use as compared to Non-OC users (50%)." | 1.39 | Oral contraceptive use and acute mountain sickness in South Pole workers. ( Anderson, P; Harrison, MF; Johnson, BD; Johnson, J; Miller, A; O'Malley, K; Richert, M, 2013) |
| "Acetazolamide was associated with decreased AMS but was prescribed infrequently." | 1.38 | Acute mountain sickness impact among travelers to Cusco, Peru. ( Cabada, MM; Mozo, K; Salazar, H; Swanson, J; White, AC, 2012) |
| "Acute mountain sickness is the most common presentation of altitude illness and typically causes headache and malaise within six to 12 hours of gaining altitude." | 1.36 | Altitude illness: risk factors, prevention, presentation, and treatment. ( Fiore, DC; Hall, S; Shoja, P, 2010) |
| "Acetazolamide has been recognized as an effective treatment for acute mountain sickness." | 1.35 | Normoxic induction of cerebral HIF-1alpha by acetazolamide in rats: role of acidosis. ( Dou, T; Gu, G; Kang, Z; Li, R; Liu, Y; Lu, J; Ostrowski, RP; Peng, Z; Sun, X; Tao, H; Xu, J; Xu, W; Zhang, JH, 2009) |
| "High altitude pulmonary edema (HAPE) is the leading cause of death from altitude illness and rapid descent is often considered a life-saving foundation of therapy." | 1.34 | Treatment of high altitude pulmonary edema at 4240 m in Nepal. ( Fagenholz, PJ; Gutman, JA; Harris, NS; Murray, AF, 2007) |
| " This study aimed to determine whether acetazolamide is effective at dosing relevant to human use at high altitude and to investigate whether its efficacy against hypoxic pulmonary vasoconstriction is dependent on carbonic anhydrase inhibition by testing other potent heterocyclic sulfonamide carbonic anhydrase inhibitors." | 1.34 | Pulmonary vasodilation by acetazolamide during hypoxia is unrelated to carbonic anhydrase inhibition. ( Boemke, W; Francis, RC; Höhne, C; Pickerodt, PA; Swenson, ER, 2007) |
| "High-altitude pulmonary edema (HAPE) is a non-cardiogenic edema that is often preceded by symptoms of AMS." | 1.32 | [Acute mountain sickness and high-altitude pulmonary edema. How to protect the mountain climber from the effects of the "altitude haze"]. ( Bärtsch, P; Dehnert, Ch; Mairbäurl, H; Schneider, M, 2003) |
| "Acetazolamide is a useful prophylactic for acute mountain sickness causing marked reduction in headache, nausea, vomiting, weakness, etc." | 1.28 | Acetazolamide and high altitude diseases. ( Bradwell, AR; Imray, C; Winterborn, M; Wright, AD, 1992) |
| "Acute mountain sickness is not uncommon at intermediate altitudes." | 1.28 | Acute mountain sickness at intermediate altitude: military mountainous training. ( Karakla, DW; Pigman, EC, 1990) |
| "Mild forms of acute mountain sickness are treated by a rest day, whereas patients with severe disease should descend as soon as possible." | 1.26 | [Incidence, prevention and therapy of acute mountain sickness]. ( Oelz, O, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 46 (16.61) | 18.7374 |
| 1990's | 36 (13.00) | 18.2507 |
| 2000's | 74 (26.71) | 29.6817 |
| 2010's | 93 (33.57) | 24.3611 |
| 2020's | 28 (10.11) | 2.80 |
| Authors | Studies |
|---|---|
| Lipman, GS | 9 |
| Moritz Berger, M | 1 |
| Yang, HL | 1 |
| Deng, MJ | 1 |
| Zhang, W | 2 |
| Huang, S | 1 |
| Hu, Y | 2 |
| Sun, J | 1 |
| Wang, T | 1 |
| Wang, H | 1 |
| Zhao, C | 1 |
| Wang, W | 1 |
| Yan, K | 1 |
| Yan, X | 1 |
| Sun, H | 1 |
| Rothwell, A | 1 |
| Anderson, O | 1 |
| Luks, AM | 6 |
| Hackett, PH | 8 |
| Brent, MB | 1 |
| Simonsen, U | 1 |
| Thomsen, JS | 1 |
| Brüel, A | 1 |
| Alarcón, RF | 1 |
| Huayanay, R | 1 |
| Monge, E | 1 |
| Vizcarra-Vizcarra, CA | 1 |
| Chávez-Velázquez, E | 1 |
| Asato-Higa, C | 1 |
| Hurtado-Aréstegui, A | 1 |
| Pedicino, D | 1 |
| Volpe, M | 1 |
| Hundt, N | 1 |
| Apel, C | 1 |
| Bertsch, D | 1 |
| Cerfontaine, C | 1 |
| van der Giet, M | 1 |
| van der Giet, S | 1 |
| Graß, M | 1 |
| Haunolder, M | 1 |
| Heussen, NM | 1 |
| Jäger, J | 1 |
| Kühn, C | 1 |
| Morrison, A | 1 |
| Museo, S | 1 |
| Timmermann, L | 1 |
| Wernitz, K | 1 |
| Gieseler, U | 1 |
| Küpper, T | 1 |
| Reiser, AE | 1 |
| Furian, M | 1 |
| Lichtblau, M | 1 |
| Buergin, A | 1 |
| Schneider, SR | 1 |
| Appenzeller, P | 1 |
| Mayer, L | 1 |
| Muralt, L | 1 |
| Mademilov, M | 1 |
| Abdyraeva, A | 1 |
| Aidaralieva, S | 1 |
| Muratbekova, A | 1 |
| Akylbekov, A | 1 |
| Sheraliev, U | 1 |
| Shabykeeva, S | 1 |
| Sooronbaev, TM | 1 |
| Ulrich, S | 4 |
| Bloch, KE | 4 |
| Burtscher, J | 3 |
| Swenson, ER | 15 |
| Millet, GP | 1 |
| Burtscher, M | 4 |
| Li, L | 1 |
| Lin, L | 1 |
| Wen, B | 1 |
| Zhao, PC | 1 |
| Liu, DS | 1 |
| Pang, GM | 1 |
| Wang, ZR | 1 |
| Tan, Y | 1 |
| Lu, C | 1 |
| McIntosh, SE | 4 |
| Hemphill, M | 2 |
| McDevitt, MC | 2 |
| Gurung, TY | 2 |
| Ghale, M | 2 |
| Knott, JR | 2 |
| Thapa, GB | 2 |
| Basnyat, B | 17 |
| Dow, J | 2 |
| Weber, DC | 2 |
| Grissom, CK | 3 |
| Gatterer, H | 2 |
| Bernatzky, G | 1 |
| Rainer, M | 1 |
| Kayser, B | 6 |
| Tapia, L | 1 |
| Irarrázaval, S | 2 |
| Shlim, DR | 1 |
| Yurkevicius, BR | 1 |
| Bradbury, KE | 1 |
| Nixon, AC | 1 |
| Mitchell, KM | 1 |
| Luippold, AJ | 1 |
| Mayer, TA | 1 |
| Alba, BK | 1 |
| Salgado, RM | 1 |
| Charkoudian, N | 1 |
| Lu, H | 2 |
| Zhang, H | 1 |
| Jiang, Y | 1 |
| Jurkiewicz, C | 5 |
| Burnier, A | 2 |
| Marvel, J | 1 |
| Phillips, C | 6 |
| Lowry, C | 1 |
| Hawkins, J | 1 |
| Navlyt, A | 2 |
| Schilling, M | 1 |
| Hadley, R | 1 |
| Veremu, M | 1 |
| McMaster, D | 1 |
| Dawadi, S | 2 |
| Basyal, B | 1 |
| Subedi, Y | 2 |
| Richalet, JP | 7 |
| Pillard, F | 1 |
| LE Moal, D | 1 |
| Rivière, D | 1 |
| Oriol, P | 1 |
| Poussel, M | 1 |
| Chenuel, B | 1 |
| Doutreleau, S | 1 |
| Vergès, S | 1 |
| Demanez, S | 1 |
| Vergnion, M | 1 |
| Boulet, JM | 1 |
| Douard, H | 1 |
| Dupré, M | 1 |
| Mesland, O | 1 |
| Remetter, R | 1 |
| Lonsdorfer-Wolf, E | 1 |
| Frey, A | 1 |
| Vilcoq, L | 1 |
| Nedelec Jaffuel, A | 1 |
| Debeaumont, D | 1 |
| Duperrex, G | 1 |
| Lecoq, F | 1 |
| Hédon, C | 1 |
| Hayot, M | 1 |
| Giardini, G | 2 |
| Lhuissier, FJ | 1 |
| Gao, D | 1 |
| Wang, Y | 1 |
| Zhang, R | 1 |
| Zhang, Y | 3 |
| Small, E | 1 |
| Juul, N | 2 |
| Pomeranz, D | 2 |
| Burns, P | 5 |
| Cheffers, M | 2 |
| Pun, M | 4 |
| Warner, K | 3 |
| Sanders, L | 2 |
| Soto, M | 2 |
| Hackett, P | 7 |
| Deniz, S | 1 |
| Uysal, TK | 1 |
| Capasso, C | 1 |
| Supuran, CT | 1 |
| Ozensoy Guler, O | 1 |
| Caravedo, MA | 1 |
| Mozo, K | 2 |
| Morales, ML | 1 |
| Smiley, H | 1 |
| Stuart, J | 1 |
| Tilley, DH | 1 |
| Cabada, MM | 2 |
| Tarshis, S | 1 |
| Maltzahn, J | 2 |
| Loomis, Z | 2 |
| Irwin, DC | 1 |
| Davis, C | 2 |
| Phillips, L | 1 |
| Chang, Y | 1 |
| Harris, NS | 4 |
| Parise, I | 1 |
| Nieto Estrada, VH | 3 |
| Molano Franco, D | 3 |
| Medina, RD | 1 |
| Gonzalez Garay, AG | 2 |
| Martí-Carvajal, AJ | 3 |
| Arevalo-Rodriguez, I | 4 |
| Evans, K | 1 |
| Alpert, JS | 1 |
| Sridharan, K | 1 |
| Sivaramakrishnan, G | 1 |
| Hofmeyr, R | 1 |
| Tölken, G | 1 |
| De Decker, R | 1 |
| Gonzalez Garay, A | 1 |
| Williamson, J | 1 |
| Oakeshott, P | 1 |
| Dallimore, J | 1 |
| Simancas-Racines, D | 1 |
| Osorio, D | 1 |
| Franco, JV | 1 |
| Xu, Y | 1 |
| Hidalgo, R | 1 |
| Shah, P | 1 |
| Liu, X | 1 |
| Hodgetts, T | 1 |
| Sii, F | 1 |
| Simka, M | 1 |
| Latacz, P | 1 |
| Czaja, J | 1 |
| Joyce, KE | 1 |
| Lucas, SJE | 1 |
| Imray, CHE | 2 |
| Balanos, GM | 2 |
| Wright, AD | 8 |
| Li, Y | 1 |
| Clarke, AK | 1 |
| Cozzi, M | 1 |
| Wright, A | 2 |
| Pagliarini, S | 1 |
| K Grissom, C | 1 |
| Hung, PH | 1 |
| Lin, FC | 1 |
| Tsai, HC | 1 |
| Chao, HS | 1 |
| Chou, CW | 1 |
| Chang, SC | 1 |
| Bennett, R | 1 |
| Winstead-Derlega, C | 1 |
| Walker, A | 1 |
| Reilly, A | 1 |
| Romero, J | 1 |
| Salvi, P | 2 |
| Revera, M | 2 |
| Faini, A | 3 |
| Giuliano, A | 2 |
| Gregorini, F | 2 |
| Agostoni, P | 1 |
| Becerra, CG | 1 |
| Bilo, G | 3 |
| Lombardi, C | 2 |
| O'Rourke, MF | 1 |
| Mancia, G | 2 |
| Parati, G | 3 |
| Penninga, L | 1 |
| Wetterslev, J | 1 |
| Penninga, EI | 1 |
| Gluud, C | 1 |
| Bärtsch, P | 7 |
| Ke, T | 1 |
| Wang, J | 1 |
| Zhang, X | 1 |
| Chen, Y | 1 |
| Liu, M | 1 |
| Zhao, F | 1 |
| Shen, X | 1 |
| Yang, Q | 1 |
| Chen, J | 1 |
| Luo, W | 1 |
| Johnson, PL | 1 |
| Johnson, CC | 1 |
| Poudyal, P | 1 |
| Regmi, N | 1 |
| Walmsley, MA | 1 |
| Kurdziel, M | 1 |
| Canouï-Poitrine, F | 2 |
| Canou-Poitrine, F | 1 |
| Larmignat, P | 2 |
| Scherrer, U | 1 |
| Rexhaj, E | 1 |
| Rimoldi, SF | 1 |
| Colombo, ES | 1 |
| Hoffman, I | 1 |
| Harrison, MF | 2 |
| Anderson, P | 1 |
| Miller, A | 1 |
| O'Malley, K | 1 |
| Richert, M | 2 |
| Johnson, J | 1 |
| Johnson, BD | 2 |
| Cushing, T | 2 |
| Paterson, R | 1 |
| Haukoos, J | 1 |
| Fischer, R | 4 |
| Stadelmann, K | 1 |
| Latshang, TD | 3 |
| Nussbaumer-Ochsner, Y | 2 |
| Tarokh, L | 1 |
| Kohler, M | 2 |
| Achermann, P | 1 |
| Vasic, I | 1 |
| Hasler, E | 1 |
| Muehlemann, T | 1 |
| Wolf, M | 1 |
| Bradwell, AR | 11 |
| Myers, SD | 1 |
| Beazley, M | 1 |
| Ashdown, K | 1 |
| Harris, NG | 1 |
| Bradwell, SB | 1 |
| Goodhart, J | 1 |
| Imray, CH | 2 |
| Wimalasena, Y | 1 |
| Edsell, ME | 1 |
| Pattinson, KT | 3 |
| Harris, SJ | 1 |
| Eigenberger, P | 1 |
| Faino, A | 1 |
| Lisk, C | 1 |
| Frank, E | 1 |
| Frank, A | 1 |
| Schroeder, T | 1 |
| Strand, M | 1 |
| Irwin, D | 1 |
| O'Hara, R | 1 |
| Serres, J | 1 |
| Dodson, W | 1 |
| Bruce, W | 1 |
| Ordway, J | 1 |
| Powell, E | 1 |
| Wade, M | 1 |
| Faull, OK | 1 |
| Robertson, J | 1 |
| Thomas, O | 1 |
| Antoniades, CA | 1 |
| Miller, SC | 1 |
| Jean, D | 1 |
| Havryliuk, T | 1 |
| Acharya, B | 1 |
| Caruso, E | 1 |
| Wang, K | 1 |
| Smith, ZM | 1 |
| Buxton, RB | 1 |
| Dubowitz, DJ | 1 |
| Biondich, AS | 1 |
| Joslin, JD | 1 |
| Bultas, J | 1 |
| Anderson, PJ | 1 |
| Johnson, JB | 1 |
| Miller, AD | 1 |
| Wang, C | 1 |
| Wang, R | 1 |
| Xie, H | 1 |
| Sun, Y | 1 |
| Tao, R | 1 |
| Liu, W | 1 |
| Li, W | 1 |
| Jia, Z | 1 |
| Hill, AD | 1 |
| Faulhaber, M | 1 |
| Caravita, S | 1 |
| Lang, M | 1 |
| Grissom, C | 1 |
| Freer, L | 2 |
| Rivera-Ch, M | 3 |
| Huicho, L | 2 |
| Bouchet, P | 2 |
| León-Velarde, F | 4 |
| Plant, T | 1 |
| Aref-Adib, G | 1 |
| Hargrove, J | 1 |
| Holck, PS | 5 |
| Srivastav, S | 1 |
| Alekh, K | 1 |
| Ghimire, LV | 2 |
| Pandey, K | 1 |
| Griffiths, A | 1 |
| Shankar, R | 2 |
| Kaul, K | 1 |
| Paudyal, A | 1 |
| Stasiuk, D | 1 |
| Basnyat, R | 1 |
| Southard, A | 1 |
| Robinson, C | 1 |
| Shandley, T | 1 |
| Johnson, DW | 1 |
| Zafren, K | 4 |
| Williams, S | 1 |
| Weiss, EA | 2 |
| Farrar, JJ | 1 |
| Subedi, D | 2 |
| Marahatta, R | 2 |
| Sharma, S | 2 |
| Bajracharya, R | 2 |
| Hillenbrand, P | 3 |
| Soon, Y | 2 |
| van Patot, MC | 1 |
| Leadbetter, G | 1 |
| Keyes, LE | 2 |
| Maakestad, KM | 1 |
| Olson, S | 1 |
| Gertsch, JH | 6 |
| Holck, PC | 1 |
| Fagenholz, PJ | 2 |
| Gutman, JA | 2 |
| Murray, AF | 2 |
| Noble, VE | 1 |
| Camargo, CA | 1 |
| Xu, J | 1 |
| Peng, Z | 1 |
| Li, R | 1 |
| Dou, T | 1 |
| Xu, W | 1 |
| Gu, G | 1 |
| Liu, Y | 1 |
| Kang, Z | 1 |
| Tao, H | 1 |
| Zhang, JH | 1 |
| Ostrowski, RP | 1 |
| Lu, J | 1 |
| Sun, X | 1 |
| Berendsen, RR | 1 |
| Willems, JH | 1 |
| Bosch, FH | 2 |
| Hulsebosch, R | 2 |
| Szawarski, P | 2 |
| Hall-Thompson, B | 1 |
| Davies, AJ | 1 |
| Kalson, NS | 2 |
| Stokes, S | 3 |
| Earl, MD | 1 |
| Whitehead, AG | 2 |
| Frost, H | 2 |
| Tyrell-Marsh, I | 1 |
| Naylor, J | 1 |
| Earl, M | 1 |
| Tyrrell-Marsh, I | 1 |
| Davies, A | 1 |
| García Nicolás, FJ | 1 |
| Ghosh, M | 1 |
| Biswas, D | 1 |
| Mukherjee, A | 1 |
| Pratali, L | 1 |
| Cavana, M | 1 |
| Dunin-Bell, O | 1 |
| Chin, M | 1 |
| Boyle, S | 1 |
| Auerbach, PS | 1 |
| Rodway, GW | 2 |
| Schoene, RB | 3 |
| Merritt, A | 1 |
| Mulcahy, A | 1 |
| Fisher, RS | 1 |
| Allison, E | 1 |
| Hanzelka, K | 1 |
| Hazan, A | 1 |
| Meyers, Z | 1 |
| Odegaard, J | 1 |
| Pook, B | 1 |
| Thompson, M | 1 |
| Slomovic, B | 1 |
| Wahlberg, H | 1 |
| Wilshaw, V | 1 |
| Kilner, T | 1 |
| Mukerji, S | 1 |
| Fiore, DC | 1 |
| Hall, S | 1 |
| Shoja, P | 1 |
| Halverson, S | 1 |
| Gertsch, J | 1 |
| Steif, M | 1 |
| Powell, S | 1 |
| Khanal, S | 1 |
| Joshi, A | 1 |
| Karambay, J | 1 |
| Alexander, HD | 1 |
| Stone, A | 1 |
| Morrissey, C | 1 |
| Thompson, BH | 1 |
| Farrar, J | 1 |
| Subudhi, AW | 2 |
| Dimmen, AC | 2 |
| Julian, CG | 2 |
| Wilson, MJ | 2 |
| Panerai, RB | 1 |
| Roach, RC | 6 |
| DeLellis, SM | 1 |
| Pecha, T | 1 |
| Murdoch, D | 4 |
| Kitsteiner, JM | 1 |
| Whitworth, JD | 1 |
| Nashelsky, J | 1 |
| Firth, PG | 1 |
| Gray, C | 1 |
| Novis, CA | 1 |
| Poitrine, E | 1 |
| Letournel, M | 1 |
| Seupaul, RA | 1 |
| Welch, JL | 1 |
| Malka, ST | 1 |
| Emmett, TW | 1 |
| Pichon, A | 1 |
| Connes, P | 1 |
| Quidu, P | 1 |
| Marchant, D | 1 |
| Brunet, J | 1 |
| Levy, BI | 1 |
| Vilar, J | 1 |
| Safeukui, I | 1 |
| Cymbalista, F | 1 |
| Maignan, M | 2 |
| Favret, F | 1 |
| Lisi, E | 1 |
| Salerno, S | 1 |
| Ramos Becerra, CG | 1 |
| Dumont, L | 4 |
| Lysakowski, C | 2 |
| Combescure, C | 1 |
| Haller, G | 1 |
| Tramèr, MR | 4 |
| Salazar, H | 1 |
| Swanson, J | 1 |
| White, AC | 1 |
| Wagner, DR | 2 |
| Cushing, TA | 1 |
| Jones, BE | 1 |
| McKenzie, S | 1 |
| Nilles, E | 1 |
| Stoddard, GJ | 1 |
| Low, EV | 1 |
| Avery, AJ | 1 |
| Gupta, V | 1 |
| Schedlbauer, A | 1 |
| Grocott, MP | 1 |
| Imray, C | 3 |
| Dennie, ML | 1 |
| Bayley, EW | 1 |
| Schneider, M | 3 |
| Bernasch, D | 1 |
| Weymann, J | 1 |
| Holle, R | 1 |
| Dehnert, Ch | 1 |
| Mairbäurl, H | 1 |
| Johnson, EW | 3 |
| Castro-Marin, F | 1 |
| Inoue, Y | 1 |
| Yeh, C | 1 |
| Murdoch, DR | 1 |
| Pattinson, K | 1 |
| Mardirosoff, C | 3 |
| Vollmar, C | 1 |
| Thiere, M | 2 |
| Born, C | 1 |
| Leitl, M | 2 |
| Pfluger, T | 1 |
| Huber, RM | 2 |
| Hussain, MM | 2 |
| Aslam, M | 3 |
| Lang, SM | 1 |
| Steiner, U | 1 |
| Beazley, MF | 1 |
| Chesner, IM | 2 |
| Clayton, RN | 1 |
| Forster, PJ | 2 |
| Onopa, J | 1 |
| Carlsten, C | 1 |
| Ruoss, S | 1 |
| Adams, J | 1 |
| Elphick, HL | 1 |
| Elphick, DA | 1 |
| Bailey, DM | 1 |
| Berger, MM | 1 |
| Knauth, M | 1 |
| Baumgartner, RW | 1 |
| Weil, JV | 3 |
| Gaillard, S | 1 |
| Dellasanta, P | 1 |
| Loutan, L | 1 |
| Chow, T | 1 |
| Browne, V | 1 |
| Heileson, HL | 1 |
| Wallace, D | 1 |
| Anholm, J | 1 |
| Green, SM | 1 |
| Rivera, M | 1 |
| Chirinos, E | 1 |
| Onnen, I | 1 |
| Petitjean, O | 2 |
| Bienvenu, A | 1 |
| Lasne, F | 1 |
| Moutereau, S | 1 |
| Schreijer, AJ | 1 |
| Cannegieter, SC | 1 |
| Rosendaal, FR | 1 |
| Helmerhorst, FM | 1 |
| Donham, BP | 1 |
| Fleischman, RJ | 1 |
| Gowder, DW | 1 |
| Hawksworth, JS | 1 |
| Jensen, BT | 1 |
| Kleiman, RJ | 1 |
| Loveridge, AH | 1 |
| Lundeen, EB | 1 |
| Newman, SL | 1 |
| Noboa, JA | 1 |
| Miegs, DP | 1 |
| O'Beirne, KA | 1 |
| Philpot, KB | 1 |
| Schultz, MN | 1 |
| Valente, MC | 1 |
| Wiebers, MR | 1 |
| Davis, PR | 1 |
| Mason, NP | 1 |
| Richards, P | 1 |
| Hillebrandt, D | 1 |
| Pahari, AK | 1 |
| Gurung, P | 1 |
| Lal, BK | 1 |
| Pradhan, S | 1 |
| Rai, D | 1 |
| Höhne, C | 1 |
| Pickerodt, PA | 1 |
| Francis, RC | 1 |
| Boemke, W | 1 |
| Leaf, DE | 1 |
| Goldfarb, DS | 1 |
| Teppema, LJ | 2 |
| Steinback, CD | 1 |
| Brown, AD | 1 |
| Foster, GE | 1 |
| Duff, HJ | 1 |
| Leigh, R | 1 |
| Poulin, MJ | 1 |
| Vuyk, J | 1 |
| Van Den Bos, J | 1 |
| Terhell, K | 1 |
| De Bos, R | 1 |
| Vletter, A | 1 |
| Valk, P | 1 |
| Van Beuzekom, M | 1 |
| Van Kleef, J | 1 |
| Dahan, A | 1 |
| Fargo, JD | 1 |
| Parker, D | 1 |
| Tatsugawa, K | 1 |
| Young, TA | 1 |
| Merritt, AL | 1 |
| Camerlengo, A | 1 |
| Meyer, C | 1 |
| Mull, JD | 1 |
| Moraga, FA | 1 |
| Flores, A | 1 |
| Serra, J | 1 |
| Esnaola, C | 1 |
| Barriento, C | 1 |
| Brearey, S | 1 |
| Morris, DS | 1 |
| Severn, PS | 1 |
| Smith, J | 1 |
| Somner, JE | 1 |
| Stannard, KP | 1 |
| Cottrell, DG | 1 |
| Bosch, F | 1 |
| Sanner, B | 1 |
| Schäfer, T | 1 |
| Privat, C | 1 |
| Pham, I | 1 |
| Macarlupu, JL | 1 |
| Delamere, JP | 2 |
| Mackintosh, JH | 2 |
| Meyers, D | 1 |
| Sutton, JR | 2 |
| Powles, AC | 2 |
| Jones, NL | 1 |
| Forster, P | 1 |
| Walker, E | 1 |
| Williams, G | 1 |
| Fletcher, RF | 2 |
| Houston, CS | 2 |
| Jain, SC | 2 |
| Singh, MV | 2 |
| Rawal, SB | 2 |
| Greene, MK | 1 |
| Kerr, AM | 1 |
| McIntosh, IB | 2 |
| Prescott, RJ | 2 |
| Mountain, RD | 1 |
| Larson, EB | 3 |
| Hornbein, TF | 1 |
| Oelz, O | 2 |
| Fahrenwald, R | 1 |
| MacLaren, RE | 1 |
| Berghold, F | 1 |
| Schobersberger, W | 1 |
| Hsia, CC | 1 |
| Wilson, MD | 1 |
| Hart, LL | 1 |
| Maggiorini, M | 2 |
| Mirrakhlmov, M | 1 |
| Brimkulov, N | 1 |
| Cieslicki, J | 1 |
| Tobiasz, M | 1 |
| Kudaiberdiev, Z | 1 |
| Moldotashev, I | 1 |
| Shmidt, G | 1 |
| Zielinski, J | 1 |
| Meyer, BH | 1 |
| Coote, JH | 6 |
| Roberts, MJ | 1 |
| Khan, MZ | 1 |
| Fisher, JA | 1 |
| Ritschel, WA | 2 |
| Paulos, C | 2 |
| Arancibia, A | 2 |
| Agrawal, MA | 2 |
| Wetzelsberger, KM | 2 |
| Lücker, PW | 2 |
| Crowley, JS | 1 |
| Straughan, CA | 1 |
| Lee, V | 1 |
| Johnson, PA | 1 |
| Bernhard, WN | 1 |
| Schalick, LM | 1 |
| Delaney, PA | 1 |
| Bernhard, TM | 1 |
| Barnas, GM | 1 |
| Meurer, LN | 1 |
| Slawson, JG | 1 |
| Wallis, L | 1 |
| Matthews, J | 1 |
| Khan, Z | 1 |
| Ogilvie, RI | 1 |
| Laemmle, T | 1 |
| Litch, JA | 1 |
| Likar, R | 1 |
| Rennie, D | 2 |
| Levine, HD | 1 |
| Ramsay, LE | 1 |
| Mansell, AL | 1 |
| McFadden, MD | 1 |
| Hackett, PM | 1 |
| Rigg, JR | 1 |
| Olzowy, M | 1 |
| Evans, WO | 1 |
| Robinson, SM | 1 |
| Horstman, DH | 1 |
| Jackson, RE | 1 |
| Weiskopf, RB | 1 |
| Hall, IP | 1 |
| Cole, AT | 1 |
| Winterborn, M | 1 |
| Burki, NK | 1 |
| Khan, SA | 1 |
| Hameed, MA | 1 |
| Sarnquist, FH | 1 |
| McMurdo, ME | 1 |
| Hutchison, GL | 1 |
| Lindsay, G | 1 |
| Ellsworth, AJ | 2 |
| Meyer, EF | 1 |
| Bashir, Y | 1 |
| Kann, M | 1 |
| Stradling, JR | 1 |
| Elnicki, DM | 1 |
| Jensen, JB | 1 |
| Lassen, NA | 1 |
| Harvey, TC | 1 |
| Winterborn, MH | 1 |
| Raichle, ME | 1 |
| Naeije, R | 1 |
| Mélot, C | 1 |
| Pigman, EC | 1 |
| Karakla, DW | 1 |
| Miller, LG | 1 |
| Miller, SM | 1 |
| Nicholson, AN | 1 |
| Smith, PA | 1 |
| Stone, BM | 1 |
| Zell, SC | 1 |
| Goodman, PH | 1 |
| Nuki, G | 1 |
| Rylance, HJ | 1 |
| Wallace, RC | 1 |
| Dickinson, JG | 1 |
| Strickland, D | 1 |
| Thomas, DJ | 1 |
| Olive, JE | 1 |
| Knight, RJ | 1 |
| Clarke, C | 1 |
| Cook, L | 1 |
| Lala, S | 1 |
| Huang, SY | 1 |
| McCullough, RE | 1 |
| McCullough, RG | 1 |
| Micco, AJ | 1 |
| Manco-Johnson, M | 1 |
| Reeves, JT | 1 |
| Vautier, R | 1 |
| Simonsen, L | 1 |
| Steinmetz, H | 1 |
| Sjøgren, P | 1 |
| Binns, N | 1 |
| Singh, BM | 1 |
| Morrissey, SC | 1 |
| Keohane, K | 1 |
| Sharma, VM | 1 |
| Tyagi, AK | 1 |
| Foulke, GE | 1 |
| Wilson, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Sickness Evaluation at Altitude With Acetazolamide at Relative Doses[NCT03828474] | Phase 1 | 108 participants (Actual) | Interventional | 2019-08-09 | Completed | ||
| Multicentric Evaluation of the Impact on Hypoxia Sensitivity of Patients With COVID-19[NCT05167357] | 90 participants (Anticipated) | Interventional | 2021-03-18 | Recruiting | |||
| Multicenter Randomized Double-Blind Control Trial Evaluating the Utility of Continuous Positive Airway Pressure (CPAP) in the Treatment of High Altitude Pulmonary Edema (HAPE)[NCT04186598] | 264 participants (Anticipated) | Interventional | 2020-01-20 | Recruiting | |||
| A Randomized Controlled Trial of Altitude Sickness Prevention and Efficacy of Comparative Treatments[NCT02604173] | Phase 3 | 103 participants (Actual) | Interventional | 2016-08-31 | Completed | ||
| Altitude Sickness Prevention With Ibuprofen Relative to Acetazolamide and Treatment Efficacy[NCT03154645] | Phase 1 | 92 participants (Actual) | Interventional | 2017-08-12 | Completed | ||
| Controlled Hyperventilation as Prophylaxis for Acute Mountain Sickness: A Randomized Controlled Trial[NCT02972411] | 30 participants (Anticipated) | Interventional | 2016-10-31 | Recruiting | |||
| Comparison of Effectiveness Between Continuous Positive Airway Pressure (CPAP) and Hyperbaric Chamber Ventilation for the Patients of High Altitude Pulmonary Edema (HAPE) When Given in Addition to Standard of care-a Randomized Control Trial[NCT04710953] | 30 participants (Anticipated) | Interventional | 2021-04-30 | Not yet recruiting | |||
| Treatment of Patients With the Obstructive Sleep Apnea Syndrome at Altitude[NCT00714740] | Phase 4 | 49 participants (Actual) | Interventional | 2008-06-30 | Completed | ||
| Continuous Positive Airway Pressure (CPAP) and Acetazolamide for Treatment of Patients With the Obstructive Sleep Apnea Syndrome at Altitude[NCT00928655] | Phase 4 | 51 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| Treatment of High-altitude Sleep Disturbance: A Double-blind Comparison of Temazepam Versus Acetazolamide.[NCT01519544] | 34 participants (Actual) | Interventional | 2012-03-31 | Completed | |||
| Acute Mountain Sickness Treatment: A Double-blind Comparison of Metoclopramide vs. Ibuprofen[NCT01522326] | 300 participants (Anticipated) | Interventional | 2012-03-01 | Completed | |||
| Study of Periodic Breathing in Healthy Humans[NCT02201875] | 120 participants (Anticipated) | Observational | 2014-09-30 | Not yet recruiting | |||
| Calibration of a New Reflectance Oximeter.[NCT02842255] | 10 participants (Actual) | Interventional | 2015-10-31 | Completed | |||
| Pik Lenin High Altitude Research Expedition 2009, a Follow-up Project of the Muztagh Ata High Altitude Research Expedition 2005[NCT01571687] | 30 participants (Actual) | Interventional | 2009-04-30 | Completed | |||
| Can Rhodiola Crenulata Intake Improve Oxygen Saturation and Decrease the Incidence of Acute Mountain Sickness.[NCT01536288] | Phase 2 | 125 participants (Actual) | Interventional | 2010-10-31 | Completed | ||
| Observational Study of Skin Erythema by Spectrophotometer, and UV Exposure With Viospore Ultraviolet Monitors at Extreme Altitude (Mt. Everest, North Side)[NCT00685438] | 25 participants (Actual) | Observational | 2007-04-30 | Completed | |||
| Hypoventilation and High Altitude Chronic Polycythemia: Acetazolamide as a Possible Treatment[NCT00424970] | Phase 4 | 55 participants (Anticipated) | Interventional | 2007-01-31 | Completed | ||
| Randomized Controlled Trial of N-acetylcysteine and Acetazolamide in Treatment of Chronic Mountain Sickness[NCT01187108] | Phase 1/Phase 2 | 85 participants (Actual) | Interventional | 2013-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Number of participants with acute mountain sickness (AMS) by Lake Lousie Questionnaire (LLQ) (NCT02604173)
Timeframe: 24 hours
| Intervention | Count of participants (Number) |
|---|---|
| Budesonide | 24 |
| Acetazolamide | 22 |
| Control | 15 |
Number of participants with severe acute mountain sickness (AMS) by Lake Lousie Questionnaire (LLQ) (score > 5). (NCT02604173)
Timeframe: 24 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Budesonide | 18 |
| Acetazolamide | 11 |
| Control | 19 |
measurement of oxygen saturation (%) by finger tip pulse oximeter. (NCT02604173)
Timeframe: 24 hours
| Intervention | percent saturation (Mean) |
|---|---|
| Budesonide | 88.6 |
| Acetazolamide | 88.1 |
| Control | 86.4 |
59 reviews available for acetazolamide and Altitude Hypoxia
| Article | Year |
|---|---|
[The preventive effect of four drugs on acute mountain sickness: a Bayesian network meta-analysis].
Topics: Acetazolamide; Acute Disease; Altitude; Altitude Sickness; Chronic Disease; Humans; Network Meta-Ana | 2021 |
Compound Danshen Dripping Pill inhibits high altitude-induced hypoxic damage by suppressing oxidative stress and inflammatory responses.
Topics: Acetazolamide; Altitude Sickness; Animals; Blood Gas Analysis; Camphanes; Cytokines; Dose-Response R | 2021 |
Medical Conditions and High-Altitude Travel.
Topics: Acetazolamide; Altitude; Altitude Sickness; Brain Edema; Chronic Disease; Dexamethasone; Female; Hum | 2022 |
Flying to high-altitude destinations: Is the risk of acute mountain sickness greater?
Topics: Acetazolamide; Acute Disease; Adult; Air Travel; Altitude; Altitude Sickness; Humans | 2023 |
Promising Natural Medicines for the Treatment of High-Altitude Illness.
Topics: Acetazolamide; Acute Disease; Altitude; Altitude Sickness; Brain Edema; Humans | 2023 |
Expanded table: some drugs for altitude illness, jet lag, and motion sickness.
Topics: Acetazolamide; Altitude Sickness; Antiemetics; Carbonic Anhydrase Inhibitors; Central Nervous System | 2019 |
Acetazolamide for the treatment of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Carbonic Anhydrase Inhibitors; Databases, Factual; | 2019 |
Methazolamide in high-altitude illnesses.
Topics: Acetazolamide; Altitude Sickness; Humans; Hypoxia; Methazolamide; Oxidative Stress; Oxygen; Polycyth | 2020 |
Ibuprofen versus acetazolamide for prevention of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Anti-Inflammatory Agents, Non-Steroidal; Carbonic A | 2020 |
COVID-19 Lung Injury and High-Altitude Pulmonary Edema. A False Equation with Dangerous Implications.
Topics: Acetazolamide; Altitude Sickness; Betacoronavirus; Carbonic Anhydrase Inhibitors; Coronavirus Infect | 2020 |
Efficacy of Acetazolamide for the Prophylaxis of Acute Mountain Sickness: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials.
Topics: Acetazolamide; Altitude Sickness; Carbonic Anhydrase Inhibitors; Humans; Randomized Controlled Trial | 2021 |
Advances in the Prevention and Treatment of High Altitude Illness.
Topics: Acetazolamide; Altitude; Altitude Sickness; Anti-Inflammatory Agents; Anticonvulsants; Brain Edema; | 2017 |
Travelling safely to places at high altitude - Understanding and preventing altitude illness.
Topics: Acclimatization; Acetazolamide; Altitude; Altitude Sickness; Anticonvulsants; Antiemetics; Calcium C | 2017 |
Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs.
Topics: Acetazolamide; Adolescent; Adult; Aged; Altitude Sickness; Brain Edema; Budesonide; Carbonic Anhydra | 2017 |
Interventions for preventing high altitude illness: Part 2. Less commonly-used drugs.
Topics: Acetazolamide; Altitude Sickness; Cathartics; Citric Acid; Diuretics; Humans; Organometallic Compoun | 2018 |
Altitude sickness and acetazolamide.
Topics: Acetazolamide; Altitude; Altitude Sickness; Humans; Mountaineering; Risk Factors | 2018 |
Interventions for treating acute high altitude illness.
Topics: Acetazolamide; Acute Disease; Adolescent; Adult; Altitude Sickness; Amines; Anticonvulsants; Atmosph | 2018 |
Possible Role of Glymphatic System of the Brain in the Pathogenesis of High-Altitude Cerebral Edema.
Topics: Acetazolamide; Altitude; Altitude Sickness; Animals; Aquaporin 4; Astrocytes; Brain; Brain Edema; Gl | 2018 |
Advances in the available non-biological pharmacotherapy prevention and treatment of acute mountain sickness and high altitude cerebral and pulmonary oedema.
Topics: Acetazolamide; Acute Disease; Altitude; Altitude Sickness; Animals; Brain Edema; Calcium Channel Blo | 2018 |
Research advances in pathogenesis and prophylactic measures of acute high altitude illness.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Calcium Channel Blockers; Carbonic Anhydrase Inhibi | 2018 |
Interventions for preventing high altitude illness: Part 3. Miscellaneous and non-pharmacological interventions.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Ginkgo biloba; Humans; Hypertension, Pulmonary; Medro | 2019 |
Clinical practice: Acute high-altitude illnesses.
Topics: Acclimatization; Acetazolamide; Acute Disease; Altitude Sickness; Brain Edema; Dexamethasone; Humans | 2013 |
Clinical practice: Acute high-altitude illnesses.
Topics: Acclimatization; Acetazolamide; Acute Disease; Altitude Sickness; Brain Edema; Dexamethasone; Humans | 2013 |
Clinical practice: Acute high-altitude illnesses.
Topics: Acclimatization; Acetazolamide; Acute Disease; Altitude Sickness; Brain Edema; Dexamethasone; Humans | 2013 |
Clinical practice: Acute high-altitude illnesses.
Topics: Acclimatization; Acetazolamide; Acute Disease; Altitude Sickness; Brain Edema; Dexamethasone; Humans | 2013 |
Carbonic anhydrase inhibitors and high altitude illnesses.
Topics: Acetazolamide; Alkalosis; Altitude; Altitude Sickness; Carbonic Anhydrase Inhibitors; Carbonic Anhyd | 2014 |
The use of dexamethasone in support of high-altitude ground operations and physical performance: review of the literature.
Topics: Acclimatization; Acetazolamide; Altitude; Altitude Sickness; Carbonic Anhydrase Inhibitors; Cognitio | 2014 |
Patients with Obstructive Sleep Apnea at Altitude.
Topics: Acetazolamide; Age Factors; Aged; Altitude; Altitude Sickness; Arrhythmias, Cardiac; Carbonic Anhydr | 2015 |
Travelling to new heights: practical high altitude medicine.
Topics: Acclimatization; Acetazolamide; Acute Disease; Altitude; Altitude Sickness; Brain Edema; Cold Temper | 2008 |
Which medications are safe and effective for improving sleep at high altitude?
Topics: Acetamides; Acetazolamide; Altitude Sickness; Anti-Anxiety Agents; Azabicyclo Compounds; Benzodiazep | 2008 |
Altitude sickness.
Topics: Acetazolamide; Acute Disease; Altitude; Altitude Sickness; Ginkgo biloba; Humans; Pulmonary Edema | 2010 |
Pharmacologic prophylaxis for acute mountain sickness: a systematic shortcut review.
Topics: Acetazolamide; Altitude Sickness; Amines; Carbonic Anhydrase Inhibitors; Cyclohexanecarboxylic Acids | 2012 |
Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis.
Topics: Acetazolamide; Altitude Sickness; Carbonic Anhydrase Inhibitors; Humans; Paresthesia; Polyuria; Tast | 2012 |
Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Bias; Carbonic Anhydrase Inhibitors; Databases, Bib | 2012 |
Into thinner air.
Topics: Acclimatization; Acetazolamide; Altitude Sickness; Carbonic Anhydrase Inhibitors; Dehydration; Diure | 2002 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Ginkgo biloba; Humans; Phytotherapy; Pulmonary Edema; | 2003 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Ginkgo biloba; Humans; Phytotherapy; Pulmonary Edema; | 2003 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Ginkgo biloba; Humans; Phytotherapy; Pulmonary Edema; | 2003 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Ginkgo biloba; Humans; Phytotherapy; Pulmonary Edema; | 2003 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Ginkgo biloba; Humans; Phytotherapy; Pulmonary Edema; | 2003 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Ginkgo biloba; Humans; Phytotherapy; Pulmonary Edema; | 2003 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Ginkgo biloba; Humans; Phytotherapy; Pulmonary Edema; | 2003 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Ginkgo biloba; Humans; Phytotherapy; Pulmonary Edema; | 2003 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Ginkgo biloba; Humans; Phytotherapy; Pulmonary Edema; | 2003 |
Acute mountain sickness: controversies and advances.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Carbonic Anhydrase Inhibitors; Dose-Response Relation | 2004 |
High altitude cerebral edema.
Topics: Acetazolamide; Adult; Altitude Sickness; Brain Edema; Carbonic Anhydrase Inhibitors; Child; Consciou | 2004 |
Sleep at high altitude.
Topics: Acetazolamide; Altitude Sickness; Benzodiazepines; Carbonic Anhydrase Inhibitors; Chronic Disease; H | 2004 |
[Visiting high altitudes--healthy persons and patients with risk diseases].
Topics: Acclimatization; Acetazolamide; Acute Disease; Altitude; Altitude Sickness; Anti-Inflammatory Agents | 2004 |
Altitude sickness.
Topics: Acclimatization; Acetazolamide; Altitude Sickness; Dexamethasone; Humans | 2004 |
Altitude sickness.
Topics: Acclimatization; Acetazolamide; Altitude Sickness; Dexamethasone; Humans | 2004 |
High altitude illness.
Topics: Acetazolamide; Altitude; Altitude Sickness; Brain Edema; Chemoprevention; Humans; Hyperbaric Oxygena | 2005 |
Altitude sickness.
Topics: Acclimatization; Acetazolamide; Altitude Sickness; Dexamethasone; Humans | 2005 |
Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness.
Topics: Acetazolamide; Adaptation, Physiological; Altitude Sickness; Carbonic Anhydrase Inhibitors; Humans; | 2007 |
Treatment of chronic mountain sickness: critical reappraisal of an old problem.
Topics: Acclimatization; Acetazolamide; Altitude; Altitude Sickness; Angiotensin-Converting Enzyme Inhibitor | 2007 |
High hopes at high altitudes: pharmacotherapy for acute mountain sickness and high-altitude cerebral and pulmonary oedema.
Topics: Acclimatization; Acetazolamide; Acute Disease; Altitude Sickness; Antioxidants; Brain Edema; Calcium | 2008 |
[Central sleep apnea syndrome].
Topics: Acetazolamide; Altitude Sickness; Anticonvulsants; Bronchodilator Agents; Cardiovascular Diseases; C | 2008 |
Selections from current literature: the traveller to high altitude.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Child; Dexamethasone; Humans; Research Desig | 1995 |
[Etiology, clinical aspects and therapy of altitude sickness].
Topics: Acclimatization; Acetazolamide; Altitude Sickness; Aspirin; Calcium Channel Blockers; Combined Modal | 1994 |
Southwestern Internal Medicine Conference: pulmonary complications of high-altitude exposure.
Topics: Acclimatization; Acetazolamide; Acute Disease; Altitude; Altitude Sickness; Carbon Dioxide; Cardiac | 1994 |
Prophylaxis and treatment of altitude sickness with dexamethasone.
Topics: Acetazolamide; Altitude Sickness; Dexamethasone; Double-Blind Method; Humans; Mountaineering; Prospe | 1993 |
[Prevention and therapy of altitude sickness].
Topics: Acetazolamide; Altitude Sickness; Dexamethasone; Humans; Hyperbaric Oxygenation; Nifedipine | 1993 |
Medicine and mechanisms in altitude sickness. Recommendations.
Topics: Acetazolamide; Altitude Sickness; Carbonic Anhydrase Inhibitors; Dexamethasone; Glucocorticoids; Hum | 1995 |
The role of drugs in high altitude disorders.
Topics: Acetazolamide; Altitude Sickness; Calcium Channel Blockers; Dexamethasone; Glucocorticoids; Humans; | 1996 |
Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Calcium Channel Blockers; Confidence Intervals; Dex | 2000 |
[Mountaineering and altitude sickness].
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Brain Edema; Diuretics; Glucocorticoids; Humans; Mo | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
High-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Calcium Channel Blockers; Diagnosis, Differential; Di | 2001 |
Pharmacological control of altitude sickness.
Topics: Acetazolamide; Altitude Sickness; Humans | 1991 |
Mountain sickness.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Brain Edema; Dexamethasone; Female; Humans; | 1990 |
Acetazolamide in acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Humans; Hypoxia | 1987 |
Altitude-related illness.
Topics: Acetazolamide; Altitude Sickness; Atmospheric Pressure; Brain Edema; Carbon Dioxide; Cardiovascular | 1985 |
67 trials available for acetazolamide and Altitude Hypoxia
| Article | Year |
|---|---|
Effect of acetazolamide on visuomotor performance at high altitude in healthy people 40 years of age or older-RCT.
Topics: Acetazolamide; Adult; Aged; Altitude; Altitude Sickness; Double-Blind Method; Humans; Hypoxia; Middl | 2023 |
Are Pre-Ascent Low-Altitude Saliva Cortisol Levels Related to the Subsequent Acute Mountain Sickness Score? Observations from a Field Study.
Topics: Acetazolamide; Acute Disease; Adult; Altitude; Altitude Sickness; Diuretics; Environmental Exposure; | 2019 |
A Randomized Controlled Trial of the Lowest Effective Dose of Acetazolamide for Acute Mountain Sickness Prevention.
Topics: Acetazolamide; Altitude Sickness; Carbonic Anhydrase Inhibitors; Dose-Response Relationship, Drug; D | 2020 |
Predictive Capacity of Pulmonary Function Tests for Acute Mountain Sickness.
Topics: Acetazolamide; Acute Disease; Altitude; Altitude Sickness; Humans; Respiratory Function Tests; Vital | 2021 |
Budesonide Versus Acetazolamide for Prevention of Acute Mountain Sickness.
Topics: Acetazolamide; Administration, Inhalation; Administration, Oral; Adult; Altitude Sickness; Budesonid | 2018 |
Altitude Sickness Prevention with Ibuprofen Relative to Acetazolamide.
Topics: Acetazolamide; Adult; Altitude Sickness; California; Carbonic Anhydrase Inhibitors; Cyclooxygenase I | 2019 |
Analysis of Retinal Segmentation Changes at High Altitude With and Without Acetazolamide.
Topics: Acetazolamide; Administration, Oral; Adult; Aged; Altitude Sickness; Carbonic Anhydrase Inhibitors; | 2019 |
Reduced Acetazolamide Dosing in Countering Altitude Illness: A Comparison of 62.5 vs 125 mg (the RADICAL Trial).
Topics: Acetazolamide; Adult; Altitude Sickness; Carbonic Anhydrase Inhibitors; Double-Blind Method; Female; | 2019 |
Day of Ascent Dosing of Acetazolamide for Prevention of Acute Mountain Sickness.
Topics: Acetazolamide; Adult; Altitude Sickness; Carbonic Anhydrase Inhibitors; Double-Blind Method; Drug Ch | 2019 |
Changes in subendocardial viability ratio with acute high-altitude exposure and protective role of acetazolamide.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Carbonic Anhydrase Inhibitors; Coronary Circ | 2013 |
Effect of acetazolamide and gingko biloba on the human pulmonary vascular response to an acute altitude ascent.
Topics: Acetazolamide; Acute Disease; Adolescent; Altitude Sickness; Antihypertensive Agents; Double-Blind M | 2013 |
Impact of acetazolamide and CPAP on cortical activity in obstructive sleep apnea patients.
Topics: Acetazolamide; Aged; Altitude Sickness; Carbonic Anhydrase Inhibitors; Cerebral Cortex; Continuous P | 2014 |
Impact of acetazolamide and CPAP on cortical activity in obstructive sleep apnea patients.
Topics: Acetazolamide; Aged; Altitude Sickness; Carbonic Anhydrase Inhibitors; Cerebral Cortex; Continuous P | 2014 |
Impact of acetazolamide and CPAP on cortical activity in obstructive sleep apnea patients.
Topics: Acetazolamide; Aged; Altitude Sickness; Carbonic Anhydrase Inhibitors; Cerebral Cortex; Continuous P | 2014 |
Impact of acetazolamide and CPAP on cortical activity in obstructive sleep apnea patients.
Topics: Acetazolamide; Aged; Altitude Sickness; Carbonic Anhydrase Inhibitors; Cerebral Cortex; Continuous P | 2014 |
Cerebral oxygenation in patients with OSA: effects of hypoxia at altitude and impact of acetazolamide.
Topics: Acetazolamide; Adult; Aged; Altitude; Altitude Sickness; Carbonic Anhydrase Inhibitors; Cerebrovascu | 2014 |
Exercise limitation of acetazolamide at altitude (3459 m).
Topics: Acclimatization; Acetazolamide; Acute Disease; Adolescent; Adult; Aged; Altitude; Altitude Sickness; | 2014 |
The effect of acetazolamide on saccadic latency at 3459 meters.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Double-Blind Method; Female; Humans; Male; M | 2015 |
Acute Mountain Sickness Symptom Severity at the South Pole: The Influence of Self-Selected Prophylaxis with Acetazolamide.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Carbonic Anhydrase Inhibitors; Female; Healt | 2016 |
Effect of acetazolamide on ventilatory response in subjects with chronic mountain sickness.
Topics: Acetazolamide; Adult; Altitude Sickness; Analysis of Variance; Anticonvulsants; Carbon Dioxide; Chro | 2008 |
Acetazolamide fails to decrease pulmonary artery pressure at high altitude in partially acclimatized humans.
Topics: Acetazolamide; Adult; Altitude Sickness; Blood Pressure; Carbonic Anhydrase Inhibitors; Dose-Respons | 2008 |
Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Carbonic Anhydrase Inhibitors; Dose-Response | 2008 |
Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation at Altitude Trial (HEAT).
Topics: Acetazolamide; Adolescent; Adult; Aged; Altitude Sickness; Anti-Inflammatory Agents, Non-Steroidal; | 2010 |
Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (spironolactone and acetazolamide trial in the prevention of acute mountain sickness group).
Topics: Acetazolamide; Adult; Altitude Sickness; Double-Blind Method; Female; Headache; Humans; Male; Mounta | 2011 |
Effects of acetazolamide and dexamethasone on cerebral hemodynamics in hypoxia.
Topics: Acetazolamide; Adult; Altitude Sickness; Anticonvulsants; Cerebrovascular Circulation; Cross-Over St | 2011 |
Acute mountain sickness, inflammation, and permeability: new insights from a blood biomarker study.
Topics: Acetazolamide; Acute Disease; Adult; Altitude; Altitude Sickness; Anti-Inflammatory Agents; Biomarke | 2011 |
Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposure.
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; Blood Flow Velocity; Blood Pressure; Brachial Art | 2013 |
Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial.
Topics: Acetazolamide; Adolescent; Adult; Aged; Altitude Sickness; Carbonic Anhydrase Inhibitors; Dose-Respo | 2003 |
No evidence of cerebral oedema in severe acute mountain sickness.
Topics: Acetazolamide; Altitude Sickness; Brain; Brain Edema; Cross-Over Studies; Double-Blind Method; Human | 2004 |
Hypoxia and pulmonary acclimatisation at 4578 m altitude: the role of acetazolamide and dexamethasone.
Topics: Acclimatization; Acetazolamide; Adult; Altitude; Altitude Sickness; Antiemetics; Case-Control Studie | 2003 |
Theophylline and acetazolamide reduce sleep-disordered breathing at high altitude.
Topics: Acetazolamide; Administration, Oral; Altitude; Altitude Sickness; Apnea; Autacoids; Blood Gas Analys | 2004 |
Medroxyprogesterone at high altitude. The effects on blood gases, cerebral regional oxygenation, and acute mountain sickness.
Topics: Acetazolamide; Adult; Aged; Altitude; Altitude Sickness; Anticonvulsants; Blood Gas Analysis; Brain; | 2004 |
Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).
Topics: Acetazolamide; Adolescent; Adult; Aged; Altitude Sickness; Double-Blind Method; Female; Ginkgo bilob | 2004 |
A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m).
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Bolivia; Carbonic Anhydrase Inhibitors; Dose | 2004 |
Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
Topics: Acetazolamide; Adult; Altitude Sickness; Carbonic Anhydrase Inhibitors; Double-Blind Method; Female; | 2005 |
Acetazolamide: a treatment for chronic mountain sickness.
Topics: Acetazolamide; Administration, Oral; Adult; Altitude Sickness; Blood Pressure; Carbonic Anhydrase In | 2005 |
Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial.
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; Carbonic Anhydrase Inhibitors; Confidence Interva | 2006 |
Prevention of acute mountain sickness by acetazolamide in Nepali porters: a double-blind controlled trial.
Topics: Acetazolamide; Acute Disease; Adolescent; Adult; Altitude Sickness; Anticonvulsants; Double-Blind Me | 2006 |
Effects of acetazolamide on ventilatory, cerebrovascular, and pulmonary vascular responses to hypoxia.
Topics: Acetazolamide; Adult; Altitude Sickness; Blood Vessels; Brain; Cerebrovascular Circulation; Double-B | 2007 |
Acetazolamide improves cerebral oxygenation during exercise at high altitude.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Analysis of Variance; Brain; Carbonic Anhydr | 2006 |
Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile.
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; Blood Pressure; Chile; Ginkgo biloba; Heart Rate; | 2007 |
Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Aspirin; Carbonic Anhydrase Inhibitors; Coho | 2008 |
Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment.
Topics: Acetazolamide; Altitude Sickness; Analysis of Variance; Carbonic Anhydrase Inhibitors; Cardiac Outpu | 2008 |
Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment.
Topics: Acetazolamide; Altitude Sickness; Analysis of Variance; Carbonic Anhydrase Inhibitors; Cardiac Outpu | 2008 |
Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment.
Topics: Acetazolamide; Altitude Sickness; Analysis of Variance; Carbonic Anhydrase Inhibitors; Cardiac Outpu | 2008 |
Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment.
Topics: Acetazolamide; Altitude Sickness; Analysis of Variance; Carbonic Anhydrase Inhibitors; Cardiac Outpu | 2008 |
Acetazolamide in control of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Carbon Dioxide; Clinical Trials as Topic; Do | 1981 |
Acetazolamide in the mountains.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Clinical Trials as Topic; Double-Blind Method; Huma | 1981 |
Methazolamide in acute mountain sickness.
Topics: Acetazolamide; Altitude Sickness; Clinical Trials as Topic; Humans; Hypoxia; Methazolamide; Thiadiaz | 1982 |
Methazolamide and acetazolamide in acute mountain sickness.
Topics: Acetazolamide; Adult; Altitude Sickness; Clinical Trials as Topic; Female; Humans; Hypoxia; Male; Me | 1983 |
Acetazolamide in prevention of acute mountain sickness: a double-blind controlled cross-over study.
Topics: Acetazolamide; Acute Disease; Adolescent; Adult; Altitude Sickness; Clinical Trials as Topic; Double | 1981 |
The effect of acetazolamide on the proteinuria of altitude.
Topics: Acetazolamide; Adult; Albuminuria; Altitude Sickness; Clinical Trials as Topic; Double-Blind Method; | 1982 |
Acute mountain sickness and acetazolamide. Clinical efficacy and effect on ventilation.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Clinical Trials as Topic; Double-Blind Metho | 1982 |
Effects of acetazolamide on overnight oxygenation and acute mountain sickness in patients with asthma.
Topics: Acclimatization; Acetazolamide; Adult; Altitude; Altitude Sickness; Asthma; Female; Humans; Hypovent | 1993 |
Urinary excretion of acetazolamide in healthy volunteers after short- and long-term exposure to high altitude.
Topics: Acetazolamide; Altitude Sickness; Carbonic Anhydrase Inhibitors; Chromatography, High Pressure Liqui | 1998 |
Pharmacokinetics of acetazolamide in healthy volunteers after short- and long-term exposure to high altitude.
Topics: Acetazolamide; Adult; Altitude Sickness; Blood Pressure; Diuretics; Erythrocyte Count; Heart Rate; H | 1998 |
Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Anti-Inflammatory Agents; Blood Gas Analysis | 1998 |
Acute mountain sickness score and hypoxemia.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Developing Countries; Dexamethasone; Double- | 2001 |
Acetazolamide for tourists to Lhasa.
Topics: Acetazolamide; Altitude Sickness; Diuretics; Female; Humans; Male; Middle Aged; Surveys and Question | 1998 |
Leukonychia following high altitude exposure.
Topics: Acetazolamide; Adult; Altitude Sickness; Carbonic Anhydrase Inhibitors; Cyclooxygenase Inhibitors; D | 2002 |
The incidence, importance, and prophylaxis of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adolescent; Adult; Age Factors; Aged; Altitude Sickness; Brain Edema; | 1976 |
The incidence, importance, and prophylaxis of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adolescent; Adult; Age Factors; Aged; Altitude Sickness; Brain Edema; | 1976 |
The incidence, importance, and prophylaxis of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adolescent; Adult; Age Factors; Aged; Altitude Sickness; Brain Edema; | 1976 |
The incidence, importance, and prophylaxis of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adolescent; Adult; Age Factors; Aged; Altitude Sickness; Brain Edema; | 1976 |
The incidence, importance, and prophylaxis of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adolescent; Adult; Age Factors; Aged; Altitude Sickness; Brain Edema; | 1976 |
The incidence, importance, and prophylaxis of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adolescent; Adult; Age Factors; Aged; Altitude Sickness; Brain Edema; | 1976 |
The incidence, importance, and prophylaxis of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adolescent; Adult; Age Factors; Aged; Altitude Sickness; Brain Edema; | 1976 |
The incidence, importance, and prophylaxis of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adolescent; Adult; Age Factors; Aged; Altitude Sickness; Brain Edema; | 1976 |
The incidence, importance, and prophylaxis of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adolescent; Adult; Age Factors; Aged; Altitude Sickness; Brain Edema; | 1976 |
Effect of acetazolamide on hypoxemia during sleep at high altitude.
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; Female; Humans; Hypoxia; Male; Mountaineering; Ox | 1979 |
[Prevention of altitude sickness].
Topics: Acclimatization; Acetazolamide; Adult; Alkalosis, Respiratory; Altitude Sickness; Blood Pressure; Ca | 1975 |
The effects of acetazolamide on the ventilatory response to high altitude hypoxia.
Topics: Acetazolamide; Adult; Altitude Sickness; Carbon Dioxide; Double-Blind Method; Humans; Male; Oxygen; | 1992 |
Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Double-Blind Method; Female; Humans; Male; M | 1992 |
Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier.
Topics: Acetazolamide; Adult; Altitude Sickness; Dexamethasone; Double-Blind Method; Female; Humans; Male; M | 1991 |
Altitude insomnia: studies during an expedition to the Himalayas.
Topics: Acetazolamide; Adult; Altitude Sickness; Anti-Anxiety Agents; Dose-Response Relationship, Drug; Elec | 1988 |
Acetazolamide and dexamethasone in the prevention of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adolescent; Adult; Altitude Sickness; Clinical Trials as Topic; Dexame | 1988 |
Acetazolamide and dexamethasone in the prevention of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adolescent; Adult; Altitude Sickness; Clinical Trials as Topic; Dexame | 1988 |
Acetazolamide and dexamethasone in the prevention of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adolescent; Adult; Altitude Sickness; Clinical Trials as Topic; Dexame | 1988 |
Acetazolamide and dexamethasone in the prevention of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adolescent; Adult; Altitude Sickness; Clinical Trials as Topic; Dexame | 1988 |
A randomized trial of dexamethasone and acetazolamide for acute mountain sickness prophylaxis.
Topics: Acetazolamide; Acute Disease; Adolescent; Adult; Altitude Sickness; Clinical Trials as Topic; Dexame | 1987 |
Acetazolamide in prevention of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Clinical Trials as Topic; Double-Blind Metho | 1986 |
The BMRES 1984 Medical Research Expedition to the Himalayas.
Topics: Acclimatization; Acetazolamide; Adult; Altitude Sickness; Double-Blind Method; Expeditions; Female; | 1987 |
Blood lactate changes during exercise at high altitude.
Topics: Acetazolamide; Altitude; Altitude Sickness; Exercise Test; Humans; Hydrogen-Ion Concentration; Hypox | 1987 |
The effect of acetazolamide on breath holding at high altitude.
Topics: Acetazolamide; Altitude; Altitude Sickness; Humans; Random Allocation; Respiration | 1987 |
151 other studies available for acetazolamide and Altitude Hypoxia
| Article | Year |
|---|---|
Re: "Altitude, Acute Mountain Sickness, and Acetazolamide: Recommendations for Rapid Ascent" by Toussaint et al.
Topics: Acetazolamide; Acute Disease; Altitude; Altitude Sickness; Humans; Mountaineering | 2021 |
Bilateral choroidal effusions after taking acetazolamide for altitude sickness.
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; Choroidal Effusions; Female; Humans; Mountaineeri | 2022 |
Effect of Acetazolamide and Zoledronate on Simulated High Altitude-Induced Bone Loss.
Topics: Absorptiometry, Photon; Acetazolamide; Altitude; Altitude Sickness; Animals; Bone Density; Cancellou | 2022 |
Poor Knowledge of Acute Mountain Sickness in Latin American Medical Students.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Cross-Sectional Studies; Dimenhydrinate; Female; Hu | 2022 |
Treatment of Focal and Segmental Glomerulosclerosis Secondary to High Altitude Polycythemia with Acetazolamide.
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; COVID-19; Female; Glomerulosclerosis, Focal Segme | 2022 |
From the management of altitude sickness to treatment of congestion in acute heart failure: a new season for acetazolamide?
Topics: Acetazolamide; Acute Disease; Altitude; Altitude Sickness; Heart Failure; Humans; Seasons | 2022 |
Variables Influencing the Pressure and Volume of the Pulmonary Circulation as Risk Factors for Developing High Altitude Pulmonary Edema (HAPE).
Topics: Acetazolamide; Aged; Altitude; Altitude Sickness; Humans; Hypertension, Pulmonary; Pulmonary Circula | 2022 |
In Reply to Dr Bennett.
Topics: Acetazolamide; Altitude; Altitude Sickness; Humans | 2019 |
The use of acetazolamide for the prevention of high-altitude illness.
Topics: Acetazolamide; Altitude; Altitude Sickness; Humans; Travel; Travel Medicine | 2020 |
Influence of Acetazolamide on Hand Strength and Manual Dexterity During a 30-h Simulated High Altitude Exposure.
Topics: Acetazolamide; Adolescent; Adult; Altitude; Altitude Sickness; Hand Strength; Humans; Male; Single-B | 2020 |
Do UK trekking companies recommend prophylactic acetazolamide for expeditions to Mount Kilimanjaro?
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Expeditions; Humans; Mountaineering; Tanzania; Unit | 2021 |
Morbidity Among Athletes Presenting for Medical Care During 3 Iterations of an Ultratrail Race in the Himalayas.
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; Athletic Injuries; Carbonic Anhydrase Inhibitors; | 2020 |
Validation of a Score for the Detection of Subjects with High Risk for Severe High-Altitude Illness.
Topics: Acclimatization; Acetazolamide; Adult; Altitude Sickness; Anticonvulsants; Decision Trees; Female; H | 2021 |
Rapid Ascent to High Altitude: Acetazolamide or Ibuprofen?
Topics: Acetazolamide; Altitude; Altitude Sickness; Humans; Ibuprofen | 2021 |
The Reply.
Topics: Acetazolamide; Altitude Sickness; Humans; Ibuprofen | 2021 |
Is carbonic anhydrase inhibition useful as a complementary therapy of Covid-19 infection?
Topics: Acetazolamide; Acid-Base Equilibrium; Altitude Sickness; Anticonvulsants; Antiviral Agents; Bicarbon | 2021 |
Risk factors for acute mountain sickness in travellers to Cusco, Peru: coca leaves, obesity and sex.
Topics: Acetazolamide; Acute Disease; Adult; Altitude; Altitude Sickness; Coca; Cohort Studies; Female; Huma | 2022 |
Preventing High Altitude Cerebral Edema in Rats with Repurposed Anti-Angiogenesis Pharmacotherapy.
Topics: Acetazolamide; Altitude; Altitude Sickness; Angiogenesis Inducing Agents; Angiogenesis Inhibitors; A | 2016 |
Findings of Cognitive Impairment at High Altitude: Relationships to Acetazolamide Use and Acute Mountain Sickness.
Topics: Acetazolamide; Acute Disease; Adult; Altitude; Altitude Sickness; Carbonic Anhydrase Inhibitors; Cog | 2017 |
Around Manaslu Ultramarathon: Diarrhea Is Still the King.
Topics: Acetaminophen; Acetazolamide; Altitude; Altitude Sickness; Analgesics, Non-Narcotic; Anti-Bacterial | 2017 |
Are You Planning to Sign Up for a Trip to Mars? Extreme Environmental Health Consequences of Space Travel.
Topics: Acetazolamide; Altitude Sickness; Budesonide; Environmental Health; Humans; Space Flight | 2018 |
Pharmacological interventions for preventing acute mountain sickness: a network meta-analysis and trial sequential analysis of randomized clinical trials.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Dexamethasone; Drug Administration Schedule; Drug T | 2018 |
Acute high-altitude illness.
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Chemoprevention; Diuretics; Humans; Hypertension, Pul | 2017 |
Acetazolamide Use in Ultrarunners at Altitude: Issues with Doping.
Topics: Acetazolamide; Altitude; Altitude Sickness; Humans; Pre-Exposure Prophylaxis; Running | 2018 |
Acetazolamide can cause acute hypercrystalluria.
Topics: Acetazolamide; Altitude Sickness; Chronic Disease; Humans; Mountaineering | 2018 |
The usefulness of prophylactic use of acetazolamide in subjects with acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Carbon Dioxide; Female; Heart Rate; Humans; | 2019 |
In Response to Reduced Acetazolamide Dose for AMS by McIntosh et al.
Topics: Acetazolamide; Altitude; Altitude Sickness; Carbonic Anhydrase Inhibitors; Humans | 2019 |
Acetazolamide for the prevention of acute mountain sickness: time to move on.
Topics: Acetazolamide; Altitude Sickness; Carbonic Anhydrase Inhibitors; Humans | 2013 |
Continuous positive airway pressure treatment for acute mountain sickness at 4240 m in the Nepal Himalaya.
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; Carbonic Anhydrase Inhibitors; Continuous Positiv | 2013 |
Continuous positive airway pressure treatment for acute mountain sickness at 4240 m in the Nepal Himalaya.
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; Carbonic Anhydrase Inhibitors; Continuous Positiv | 2013 |
Continuous positive airway pressure treatment for acute mountain sickness at 4240 m in the Nepal Himalaya.
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; Carbonic Anhydrase Inhibitors; Continuous Positiv | 2013 |
Continuous positive airway pressure treatment for acute mountain sickness at 4240 m in the Nepal Himalaya.
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; Carbonic Anhydrase Inhibitors; Continuous Positiv | 2013 |
Acetazolamide and sulfa allergy: how to deal with sulfa allergy at altitude?
Topics: Acetazolamide; Altitude; Altitude Sickness; Carbonic Anhydrase Inhibitors; Dexamethasone; Diabetes C | 2013 |
Acute high-altitude illnesses.
Topics: Acetazolamide; Altitude Sickness; Humans; Male | 2013 |
Acute high-altitude illnesses.
Topics: Acetazolamide; Altitude Sickness; Humans; Male | 2013 |
Acute high-altitude illnesses.
Topics: Acetazolamide; Altitude Sickness; Humans; Male | 2013 |
Acute high-altitude illnesses.
Topics: Acetazolamide; Altitude Sickness; Humans; Male | 2013 |
Acute high-altitude illnesses.
Topics: Acetazolamide; Altitude Sickness; Humans; Male | 2013 |
Oral contraceptive use and acute mountain sickness in South Pole workers.
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; Antarctic Regions; Anticonvulsants; Contraceptive | 2013 |
Intraocular pressure is not associated with acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Adult; Altitude; Altitude Sickness; Carbonic Anhydrase Inhibitors; Fem | 2013 |
[Acute mountain sickness : How can it be treated and how can it be avoided?].
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Anti-Inflammatory Agents; Dexamethasone; Diuretics; | 2014 |
A retrospective study of acute mountain sickness on Mt. Kilimanjaro using trekking company data.
Topics: Acetazolamide; Altitude Sickness; Antiemetics; Carbonic Anhydrase Inhibitors; Commerce; Data Collect | 2014 |
Diabetic ketoacidosis and acute mountain sickness: case report and review of treatment options in type 1 diabetes mellitus.
Topics: Acetazolamide; Adult; Altitude Sickness; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Ketoacid | 2015 |
Acetazolamide and prevention of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Carbonic Anhydrase Inhibitors; Humans | 2014 |
[Travel at high altitude].
Topics: Acetazolamide; Altitude; Altitude Sickness; Carbonic Anhydrase Inhibitors; Humans; Travel | 2015 |
Understanding of Altitude Illness and Use of Pharmacotherapy Among Trekkers and Porters in the Annapurna Region of Nepal.
Topics: Acetazolamide; Adult; Altitude Sickness; Anti-Inflammatory Agents; Dexamethasone; Female; Health Kno | 2015 |
Acetazolamide during acute hypoxia improves tissue oxygenation in the human brain.
Topics: Acetazolamide; Adult; Algorithms; Altitude Sickness; Brain Chemistry; Capillaries; Carbon Dioxide; C | 2015 |
Acetazolamide Use in an Ultra-Runner: A Complicated Treatment Consideration for AMS.
Topics: Acetazolamide; Altitude Sickness; Bhutan; Carbonic Anhydrase Inhibitors; Humans; Male; Middle Aged; | 2016 |
[Mountain sickness].
Topics: Acetazolamide; Acute Disease; Adaptation, Physiological; Altitude; Altitude Sickness; Brain Edema; C | 2015 |
Effect of acetazolamide on cytokines in rats exposed to high altitude.
Topics: Acetazolamide; Altitude Sickness; Animals; Cytokines; Lung Injury; Male; Rats; Rats, Wistar | 2016 |
Myopic Changes in a Climber after Taking Acetazolamide and the Use of Corrective Lenses to Temporize Symptoms: A Case Report from Mount Kilimanjaro.
Topics: Acetazolamide; Adult; Altitude Sickness; Eyeglasses; Female; Humans; Mountaineering; Myopia; Tanzani | 2016 |
Regarding the article of Lang et al. (2016; 219:27-32) entitled, "Blood pressure response to six-minute walk test in hypertensive subjects exposed to high altitude: Effects of antihypertensive combination treatment".
Topics: Acetazolamide; Altitude; Altitude Sickness; Antihypertensive Agents; Blood Pressure; Blood Pressure | 2016 |
Role of acetazolamide and telmisartan/nifedipine-GITS combination in antagonizing the blood pressure rise induced by high altitude exposure.
Topics: Acetazolamide; Altitude; Altitude Sickness; Benzimidazoles; Benzoates; Blood Pressure; Gastrointesti | 2016 |
Medication Use Among Mount Everest Climbers: Practice and Attitudes.
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; Attitude to Health; Expeditions; Female; Humans; | 2016 |
Trekkers' awareness of acute mountain sickness and acetazolamide.
Topics: Acetazolamide; Adolescent; Adult; Aged; Altitude Sickness; Awareness; Cross-Sectional Studies; Femal | 2008 |
Low-dose acetylsalicylic Acid analog and acetazolamide for prevention of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Aspirin; Dose-Response Relationship, Drug; Headache | 2008 |
Optic nerve sheath diameter correlates with the presence and severity of acute mountain sickness: evidence for increased intracranial pressure.
Topics: Acetazolamide; Adult; Altitude Sickness; Carbonic Anhydrase Inhibitors; Female; Heart Rate; Humans; | 2009 |
Normoxic induction of cerebral HIF-1alpha by acetazolamide in rats: role of acidosis.
Topics: Acetazolamide; Acidosis, Respiratory; Altitude Sickness; Animals; Carbonic Anhydrase Inhibitors; Cel | 2009 |
[Serious and sometimes fatal consequences of high-altitude pulmonary oedema].
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Fatal Outcome; Female; Glucocorticoids; Huma | 2008 |
Acetazolamide-induced myopia at altitude.
Topics: Acetazolamide; Adult; Altitude Sickness; Carbonic Anhydrase Inhibitors; Humans; Male; Myopia | 2009 |
Determinants of summiting success and acute mountain sickness on Mt Kilimanjaro (5895 m).
Topics: Acclimatization; Acetazolamide; Acute Disease; Altitude Sickness; Carbonic Anhydrase Inhibitors; Hum | 2009 |
Age is no barrier to success at very high altitudes.
Topics: Acclimatization; Acetazolamide; Adolescent; Adult; Age Factors; Aged; Altitude; Altitude Sickness; C | 2010 |
[Acetazolamide in high altitude trips].
Topics: Acetazolamide; Altitude; Altitude Sickness; Diuretics; Humans; Travel | 2011 |
High-altitude medicines: a short-term genotoxicity study.
Topics: Acetazolamide; Adult; Altitude Sickness; Analysis of Variance; Cell Survival; Cells, Cultured; Comet | 2010 |
[High altitude pulmonary edema: the importance of early diagnosis].
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; Dexamethasone; Diuretics; Drug Therapy, Combinati | 2010 |
Trekker behavior as one indicator of AMS knowledge.
Topics: Acetazolamide; Adult; Altitude Sickness; Awareness; Female; Health Knowledge, Attitudes, Practice; H | 2010 |
Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness.
Topics: Acetazolamide; Acute Disease; Albuterol; Altitude Sickness; Brain Edema; Carbolines; Dexamethasone; | 2010 |
Acute mountain sickness prophylaxis: knowledge, attitudes, & behaviours in the Everest region of Nepal.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Chemoprevention; Health Knowledge, Attitudes, Pract | 2010 |
Altitude illness: risk factors, prevention, presentation, and treatment.
Topics: Acclimatization; Acetazolamide; Altitude Sickness; Carbonic Anhydrase Inhibitors; Dexamethasone; Glu | 2010 |
Acetazolamide or not, prior to ascent?
Topics: Acetazolamide; Adult; Altitude Sickness; Carbonic Anhydrase Inhibitors; Cohort Studies; Dose-Respons | 2010 |
FPIN's clinical inquiries. Preventing acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Anti-Inflammatory Agents; Carbonic Anhydrase Inhibi | 2011 |
High-altitude corneal oedema associated with acetazolamide.
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; Corneal Edema; Female; Humans | 2011 |
Physiological risk factors for severe high-altitude illness: a prospective cohort study.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Brain Edema; Cohort Studies; Confidence Inte | 2012 |
Physiological risk factors for severe high-altitude illness: a prospective cohort study.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Brain Edema; Cohort Studies; Confidence Inte | 2012 |
Physiological risk factors for severe high-altitude illness: a prospective cohort study.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Brain Edema; Cohort Studies; Confidence Inte | 2012 |
Physiological risk factors for severe high-altitude illness: a prospective cohort study.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Brain Edema; Cohort Studies; Confidence Inte | 2012 |
Physiological risk factors for severe high-altitude illness: a prospective cohort study.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Brain Edema; Cohort Studies; Confidence Inte | 2012 |
Physiological risk factors for severe high-altitude illness: a prospective cohort study.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Brain Edema; Cohort Studies; Confidence Inte | 2012 |
Physiological risk factors for severe high-altitude illness: a prospective cohort study.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Brain Edema; Cohort Studies; Confidence Inte | 2012 |
Physiological risk factors for severe high-altitude illness: a prospective cohort study.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Brain Edema; Cohort Studies; Confidence Inte | 2012 |
Physiological risk factors for severe high-altitude illness: a prospective cohort study.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Brain Edema; Cohort Studies; Confidence Inte | 2012 |
Physiological risk factors for severe high-altitude illness: a prospective cohort study.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Brain Edema; Cohort Studies; Confidence Inte | 2012 |
Physiological risk factors for severe high-altitude illness: a prospective cohort study.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Brain Edema; Cohort Studies; Confidence Inte | 2012 |
Physiological risk factors for severe high-altitude illness: a prospective cohort study.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Brain Edema; Cohort Studies; Confidence Inte | 2012 |
Physiological risk factors for severe high-altitude illness: a prospective cohort study.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Brain Edema; Cohort Studies; Confidence Inte | 2012 |
Physiological risk factors for severe high-altitude illness: a prospective cohort study.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Brain Edema; Cohort Studies; Confidence Inte | 2012 |
Physiological risk factors for severe high-altitude illness: a prospective cohort study.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Brain Edema; Cohort Studies; Confidence Inte | 2012 |
Physiological risk factors for severe high-altitude illness: a prospective cohort study.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Brain Edema; Cohort Studies; Confidence Inte | 2012 |
Acetazolamide and chronic hypoxia: effects on haemorheology and pulmonary haemodynamics.
Topics: Acetazolamide; Altitude Sickness; Animals; Blood Viscosity; Blood Volume; Carbonic Anhydrase Inhibit | 2012 |
Acute mountain sickness impact among travelers to Cusco, Peru.
Topics: Acetazolamide; Acute Disease; Adolescent; Adult; Altitude Sickness; Coca; Cross-Sectional Studies; F | 2012 |
Medical and sporting ethics of high altitude mountaineering: the use of drugs and supplemental oxygen.
Topics: Acetazolamide; Altitude Sickness; Dexamethasone; Humans; Mountaineering; Nifedipine; Oxygen; Oxygen | 2012 |
Performance-enhancing drugs-commentaries.
Topics: Acetazolamide; Altitude Sickness; Dexamethasone; Humans; Mountaineering; Nifedipine; Oxygen; Oxygen | 2012 |
Pharmacologic prevention for acute mountain sickness-lack of appropriate inclusion of the available evidence.
Topics: Acetazolamide; Altitude Sickness; Carbonic Anhydrase Inhibitors; Dexamethasone; Glucocorticoids; Hum | 2012 |
Management of high altitude pulmonary edema in the Himalaya: a review of 56 cases presenting at Pheriche medical aid post (4240 m).
Topics: Acetazolamide; Altitude Sickness; Dexamethasone; Emergency Treatment; Female; Humans; Hypertension, | 2013 |
Prophylaxis for acute mountain sickness.
Topics: Acetazolamide; Altitude Sickness; Carbonic Anhydrase Inhibitors; Dexamethasone; Glucocorticoids; Hum | 2012 |
Acetazolamide for the prophylaxis of acute mountain sickness.
Topics: Acetazolamide; Altitude Sickness; Carbonic Anhydrase Inhibitors; Humans; Outcome Assessment, Health | 2012 |
Case discussion: impaired renal function and tolerance to high altitude.
Topics: Acclimatization; Acetazolamide; Altitude; Altitude Sickness; Female; Glomerular Filtration Rate; Hum | 2002 |
Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate.
Topics: Acetazolamide; Acute Disease; Adult; Alcohol Drinking; Altitude Sickness; Analgesics; Anticonvulsant | 2002 |
[Acute mountain sickness and high-altitude pulmonary edema. How to protect the mountain climber from the effects of the "altitude haze"].
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Anti-Inflammatory Agents; Carbonic Anhydrase Inhibi | 2003 |
Altitude sickness in youth groups.
Topics: Acetazolamide; Adolescent; Altitude Sickness; Humans; Mountaineering; Practice Guidelines as Topic; | 2003 |
Efficacy of low-dose acetazolamide for the prophylaxis of acute mountain sickness.
Topics: Acetazolamide; Altitude Sickness; Carbonic Anhydrase Inhibitors; Dose-Response Relationship, Drug; H | 2003 |
Ginkgo biloba and acetazolamide for acute mountain sickness: exclusion of high risk, low status groups perpetuates discrimination and inequalities.
Topics: Acetazolamide; Altitude Sickness; Ginkgo biloba; Humans; Phytotherapy; Prejudice; Randomized Control | 2004 |
Ginkgo biloba and acetazolamide for acute mountain sickness: bias in participants may underestimate effectiveness of agents.
Topics: Acetazolamide; Altitude Sickness; Ginkgo biloba; Humans; Phytotherapy; Randomized Controlled Trials | 2004 |
Awareness, prevalence, medication use, and risk factors of acute mountain sickness in tourists trekking around the Annapurnas in Nepal: a 12-year follow-up.
Topics: Acclimatization; Acetazolamide; Acute Disease; Adolescent; Adult; Age Distribution; Age Factors; Age | 2004 |
The physiologic basis of high-altitude diseases.
Topics: Acetazolamide; Altitude Sickness; Drug Therapy, Combination; Ginkgo biloba; Headache; Humans; Phytot | 2005 |
The physiologic basis of high-altitude diseases.
Topics: Acetazolamide; Altitude Sickness; Drug Therapy, Combination; Ginkgo biloba; Headache; Humans; Phytot | 2005 |
[Your patient wants to go to the mountains. You protect him from mountain sickness and altitude edema].
Topics: Acetazolamide; Altitude Sickness; Anticonvulsants; Brain Edema; Carbolines; Carbonic Anhydrase Inhib | 2005 |
A case of thrombosis at high altitude.
Topics: Acetazolamide; Adult; Aircraft; Altitude Sickness; Dehydration; Diuretics; Female; Humans; Mountaine | 2005 |
Pulmonary vasodilation by acetazolamide during hypoxia is unrelated to carbonic anhydrase inhibition.
Topics: Acetazolamide; Acid-Base Equilibrium; Altitude Sickness; Animals; Benzolamide; Carbonic Anhydrase In | 2007 |
Prevention of acute mountain sickness by acetazolamide: as yet an unfinished story.
Topics: Acetazolamide; Adaptation, Physiological; Altitude Sickness; Carbonic Anhydrase Inhibitors; Humans; | 2007 |
Variables contributing to acute mountain sickness on the summit of Mt Whitney.
Topics: Acetazolamide; Acute Disease; Age Factors; Altitude Sickness; Analgesics; Anticonvulsants; Environme | 2006 |
Mountain sickness knowledge among foreign travelers in Cuzco, Peru.
Topics: Acetazolamide; Altitude Sickness; Carbonic Anhydrase Inhibitors; Female; Health Education; Health Kn | 2007 |
Prevention of acute mountain sickness in Nepali porters: a controlled trial.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Humans; Mountaineering; Nepal | 2007 |
Statement on high-altitude illnesses. An Advisory Committee Statement (ACS).
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Canada; Dexamethasone; Humans; Methazolamide; Nifed | 2007 |
Treatment of high altitude pulmonary edema at 4240 m in Nepal.
Topics: Acetazolamide; Adult; Albuterol; Altitude; Altitude Sickness; Bed Rest; Emergency Treatment; Female; | 2007 |
High altitude and retinal detachment.
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; Carbonic Anhydrase Inhibitors; Humans; Male; Moun | 2007 |
Acetazolamide in the mountains.
Topics: Acetazolamide; Altitude Sickness; Humans; Hypertension, Pulmonary; Hypoxia | 1981 |
Acetazolamide in the mountains.
Topics: Acetazolamide; Altitude Sickness; Humans; Hypoxia; Physical Endurance | 1981 |
ABC of healthy travel. During travel and acclimatisation.
Topics: Acclimatization; Acetazolamide; Air Pressure; Aircraft; Altitude Sickness; Circadian Rhythm; Female; | 1983 |
Altitude illness.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Atmospheric Pressure; Brain Edema; Diuretics | 1984 |
Acetazolamide for acute mountain sickness.
Topics: Acetazolamide; Altitude Sickness; Humans; Hypoxia | 1983 |
The effects of acetazolamide and spironolactone on the body water distribution of rabbits during acute exposure to simulated altitude.
Topics: Acetazolamide; Altitude Sickness; Animals; Body Water; Hypoxia; Male; Rabbits; Spironolactone | 1984 |
Treatment of acute mountain sickness.
Topics: Acetazolamide; Altitude Sickness; Humans; Hypoxia; Oxygen Inhalation Therapy | 1981 |
Treatment of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Headache; Humans; Hypoxia | 1983 |
[Incidence, prevention and therapy of acute mountain sickness].
Topics: Acetazolamide; Altitude Sickness; Brain Edema; Fluid Therapy; Humans; Hypoxia; Mountaineering; Nepal | 1982 |
Medical problems at high altitude.
Topics: Acetazolamide; Altitude; Altitude Sickness; Brain Edema; Humans; Hypoxia; Pulmonary Edema | 1981 |
Retinal haemorrhage in Himalayan mountaineers.
Topics: Acetazolamide; Adult; Altitude Sickness; Female; Hemoglobins; Humans; Intraocular Pressure; Male; Mo | 1995 |
[Acute mountain sickness and high altitude pulmonary edema].
Topics: Acetazolamide; Altitude Sickness; Humans; Pulmonary Edema | 1993 |
[Acute mountain sickness and high altitude pulmonary edema].
Topics: Acetazolamide; Altitude Sickness; Dexamethasone; Humans; Nifedipine; Pulmonary Edema | 1993 |
[Altitude illness].
Topics: Acetazolamide; Adult; Altitude Sickness; Diuretics; Female; Humans; Male; Nifedipine; Pulmonary Edem | 1995 |
The use of low-dose acetazolamide to prevent mountain sickness.
Topics: Acetazolamide; Aged; Altitude Sickness; Humans; Male; Middle Aged | 1995 |
Acute mountain sickness -- experience on the roof of Africa expedition and military implications.
Topics: Acclimatization; Acetazolamide; Adolescent; Adult; Africa; Altitude Sickness; Carbonic Anhydrase Inh | 1994 |
Prophylaxis for acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Carbonic Anhydrase Inhibitors; Humans | 1998 |
Failed mountain sickness prophylaxis.
Topics: Acetazolamide; Adult; Altitude Sickness; Humans; Male; Middle Aged; Military Personnel; Mountaineeri | 1998 |
Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression.
Topics: Acetazolamide; Altitude Sickness; Animals; Carbon Dioxide; Carbonic Anhydrase Inhibitors; Depression | 1998 |
Health advice for travelers.
Topics: Acetazolamide; Altitude Sickness; Dexamethasone; Humans; Travel | 2000 |
Which pharmacologic therapies are effective in preventing acute mountain sickness?
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Carbonic Anhydrase Inhibitors; Clinical Trials as T | 2000 |
Pharmacological prevention of acute mountain sickness. Many climbers and trekkers find acetazolamide 500 mg/day to be useful.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Carbonic Anhydrase Inhibitors; Humans; Meta-Analysi | 2001 |
Pharmacological prevention of acute mountain sickness. Same ascent rates must be used to assess effectiveness of different doses of acetazolamide.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Carbonic Anhydrase Inhibitors; Humans; Meta-Analysi | 2001 |
Medical support on a Himalayan expedition.
Topics: Acetazolamide; Adult; Altitude Sickness; Anti-Inflammatory Agents; Blood Gas Analysis; Dexamethasone | 2001 |
High-altitude illness.
Topics: Acetazolamide; Adult; Altitude Sickness; Dose-Response Relationship, Drug; Humans | 2001 |
Acetazolamide (diamox) may cause frostbite at extreme altitude.
Topics: Acetazolamide; Altitude Sickness; Anticonvulsants; Dehydration; Emergency Treatment; Frostbite; Huma | 2001 |
Drug-induced hypoglycemia presenting as acute mountain sickness, after mistaking acetohexamide for acetazolamide.
Topics: Acetazolamide; Acetohexamide; Adult; Altitude Sickness; Diagnosis, Differential; Diuretics; Female; | 1996 |
Prophylaxis of acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Humans; Hypoxia; Mountaineering; Nepal; Spironolact | 1977 |
High science, present and future.
Topics: Acetazolamide; Altitude; Altitude Sickness; Humans; Hypoxia; Male; Middle Aged; Mountaineering; Oxyg | 1979 |
High altitude illness.
Topics: Acetazolamide; Adult; Age Factors; Altitude Sickness; Child; Humans; Hypoxia; Pulmonary Edema | 1977 |
Amelioration of the symptoms of acute mountain sickness by staging and acetazolamide.
Topics: Acclimatization; Acetazolamide; Adolescent; Adult; Altitude; Altitude Sickness; Carbon Dioxide; Fema | 1976 |
Altitude induced illness.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Humans | 1992 |
Acetazolamide and high altitude diseases.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Cerebrovascular Circulation; Humans; Mountaineering | 1992 |
High altitude sickness.
Topics: Acetazolamide; Altitude Sickness; Dexamethasone; Humans; Nifedipine; Oxygen Inhalation Therapy; Pulm | 1992 |
Taste disturbance with acetazolamide.
Topics: Acetazolamide; Altitude Sickness; Humans; Taste Disorders; Time Factors | 1990 |
The effect of acetazolamide on hypercapnic and eucapnic/poikilocapnic hypoxic ventilatory responses in normal subjects.
Topics: Acetazolamide; Adult; Altitude Sickness; Carbon Dioxide; Female; Humans; Hypercapnia; Hypoxia; Male; | 1990 |
Cerebral blood flow in acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Cerebrovascular Circulation; Humans; Regional Blood | 1990 |
Acute pulmonary oedema on the Ruwenzori mountain range.
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Dexamethasone; Drug Therapy, Combination; Hu | 1990 |
Acute mountain sickness at intermediate altitude: military mountainous training.
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; Humans; Hypoxia; Male; Military Personnel | 1990 |
Altered taste secondary to acetazolamide therapy.
Topics: Acetazolamide; Adult; Altitude Sickness; Dysgeusia; Female; Humans; Taste Disorders | 1990 |
Acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Humans; Hypoxia; Oxygen | 1989 |
Sleep at high altitude.
Topics: Acclimatization; Acetazolamide; Altitude Sickness; Carbon Dioxide; Humans; Hypoxia; Medroxyprogester | 1985 |
Effect of high altitude and acetazolamide on human serum and urine purines.
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; Carbon Dioxide; Creatinine; Female; Humans; Hydro | 1986 |
The effect of altitude on tests of reaction time and alertness.
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; Arousal; Humans; Methazolamide; Middle Aged; Moun | 1988 |
High altitude cerebral oedema.
Topics: Acetazolamide; Adolescent; Altitude Sickness; Brain Edema; Cerebrovascular Disorders; Female; Humans | 1988 |
Acute mountain sickness and acetazolamide.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Humans; Hypoxia; Travel | 1988 |
Usual clinical dose of acetazolamide does not alter cerebral blood flow velocity.
Topics: Acetazolamide; Adult; Altitude Sickness; Blood Flow Velocity; Cerebrovascular Circulation; Humans; H | 1988 |
Acetazolamide and acute mountain sickness.
Topics: Acetazolamide; Altitude Sickness; Humans; Hypoxia | 1988 |
[Acute altitude sickness].
Topics: Acetazolamide; Acute Disease; Adult; Altitude Sickness; Brain Edema; Female; Headache; Humans; Hypox | 1987 |
Acetazolamide prophylaxis for acute mountain sickness.
Topics: Acetazolamide; Acute Disease; Altitude Sickness; Humans; Hypoxia; Mountaineering | 1987 |
Acute mountain sickness.
Topics: Acetazolamide; Altitude Sickness; Humans; Hypoxia | 1987 |
Amelioration of acute mountain sickness: comparative study of acetazolamide and spironolactone.
Topics: Acetazolamide; Adult; Altitude Sickness; Humans; Hypoxia; Male; Spironolactone | 1986 |
Failure of acetazolamide to prevent acute mountain sickness.
Topics: Acetazolamide; Adult; Altitude Sickness; Female; Humans; Hypoxia | 1985 |